1
|
Gong Y, Zhang S, Lin D, Cai Y, Lv S, Zheng M, Hu B, Lei X, Xu N, Wang J, Huang J, Zhou Y, Zhu L, Chen Y, Jiang Q, Li S, Zhou Y. Decoding the impact of environmental shifts on snail density dynamics in the Yangtze River basin: a 26-year study. Parasit Vectors 2025; 18:156. [PMID: 40287700 PMCID: PMC12032699 DOI: 10.1186/s13071-025-06782-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2024] [Accepted: 03/28/2025] [Indexed: 04/29/2025] Open
Abstract
BACKGROUND With the intensification of climate change and human engineering activities, environmental changes have affected schistosome-transmitting snails. This study explored the influence of environmental changes on the evolution of snail populations. METHODS Data from annual snail surveys and related factors such as hydrology, temperature, vegetation, etc., on nine bottomlands from 1997 to 2022 were collected retrospectively from multiple sources. Interpretable machine learning and the Bayesian spatial-temporal model assessed the relationship between environmental change and snail density. RESULTS Between 1997 and 2003, mean snail density was in a high-level fluctuation stage. From 2003 to 2012, it declined significantly from 0.773/0.1 m2 to 0.093/0.1 m2. However, it increased by 27.6% between 2013 (0.098/0.1 m2) and 2022 (0.125/0.1 m2). Since operation of the Three Gorges Dam (TGD) began in 2003, the duration of bottomland flooding decreased from 122 days (1997-2003) to 57 days (2003-2012) and then rebounded in 2012-2022, which was noticeable in the Anhui Section. The ground surface temperature and night light index of the bottomlands increased from 1997 to 2022. After adjusting for confounding factors (e.g. rainfall, temperature, and vegetation), the relative risk (RR) of increased snail density rose with flooding duration of between 20 and 100 days but decreased with flooding duration of > 100 days. Snail density showed an "L"-shaped relationship with the night light index, and the RR of increased snail density was lower at a higher night light index. Compared with bottomlands in the first quartile cluster of ground surface temperature, bottomlands in the second, third, and fourth quartile clusters of ground surface temperature had higher snail density RR values of 1.271 (95% CI 1.082-1.493), 1.302 (95% CI 1.146-1.480), and 1.278 (1.048, 1.559), respectively. CONCLUSIONS The TGD lowered the water level and flooding duration, which were not conducive to snail population growth. However, over time, the inhibitory effect of the TGD on snails may have been weakening, especially in areas far from the TGD. In recent years, the rebound of snail density may have been related to the rise in water levels and the change in the microenvironment. Establishing an efficient monitoring and response system is crucial for precisely controlling snails.
Collapse
Affiliation(s)
- Yanfeng Gong
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Shiqing Zhang
- Department of Schistosomiasis Control and Prevention, Anhui Institute of Parasitic Diseases, Hefei, 230061, China
| | - Dandan Lin
- Jiangxi Provincial Institute of Parasitic Diseases, Nanchang, 330096, China
| | - Yu Cai
- Hunan Institute for Schistosomiasis Control, Jin'e Middle Road, Yueyang, 414021, Hunan, China
| | - Shangbiao Lv
- Jiangxi Provincial Institute of Parasitic Diseases, Nanchang, 330096, China
| | - Mao Zheng
- Hunan Institute for Schistosomiasis Control, Jin'e Middle Road, Yueyang, 414021, Hunan, China
| | - Benjiao Hu
- Hunan Institute for Schistosomiasis Control, Jin'e Middle Road, Yueyang, 414021, Hunan, China
| | - Xiaolan Lei
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Ning Xu
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Jiamin Wang
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Junhui Huang
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Yu Zhou
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Liyun Zhu
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Yue Chen
- School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Ottawa, ON, K1G 5Z3, Canada
| | - Qingwu Jiang
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China
| | - Shizhu Li
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute of Parasitic Diseases at Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), Shanghai, 200025, China.
| | - Yibiao Zhou
- Fudan University School of Public Health, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China.
- Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China.
- Fudan University Center for Tropical Disease Research, Building 8, 130 Dong'an Road, Xuhui District, Shanghai, 200032, China.
| |
Collapse
|
2
|
Wiemers P, Graf I, Addo MM, Arck PC, Diemert A. Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women. Semin Immunopathol 2025; 47:25. [PMID: 40272573 PMCID: PMC12021716 DOI: 10.1007/s00281-025-01050-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2024] [Accepted: 03/23/2025] [Indexed: 04/25/2025]
Abstract
Infectious diseases have threatened individuals and societies since the dawn of humanity. Certain population groups, including pregnant women, young children and the elderly, are particularly vulnerable to severe infections. Over the past few centuries, advances in medical standards and the availability of vaccines have reduced infection-related mortality and morbidity rates in industrialized countries. However, the global rise in temperatures and increased precipitation present a new challenge, facilitating the broader distribution of disease vectors, such as mosquitoes, bugs and ticks, to higher altitudes and latitudes. Consequently, epidemic and pandemic outbreaks associated with these vectors, such as Zika, West Nile, dengue, yellow fever, chikungunya and malaria, are increasingly impacting diverse populations. This review comprehensively examines how infections associated with climate change disproportionately affect the health and well-being of pregnant women and their unborn children. There has been a noticeable emergence of vector-borne diseases in Europe. Consequently, we stress the importance of implementing measures that effectively protect pregnant women from these increasing infections globally and regionally. We advocate for initiatives to safeguard pregnant women from these emerging threats, beginning with enhanced education to raise awareness about the evolving risks this particularly vulnerable population faces.
Collapse
Affiliation(s)
- Pauline Wiemers
- Division of Experimental Feto-Maternal Medicine, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Isabel Graf
- Division of Experimental Feto-Maternal Medicine, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - Marylyn M Addo
- Institute for Infection Research and Vaccine Development, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
- Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- German Center for Infection Research, Partner Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany
| | - Petra C Arck
- Division of Experimental Feto-Maternal Medicine, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Hamburg Center for Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Child and Adolescent Health, Partner Site Hamburg, Hamburg, Germany.
| | - Anke Diemert
- Division of Experimental Feto-Maternal Medicine, Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- German Center for Child and Adolescent Health, Partner Site Hamburg, Hamburg, Germany.
- Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20251, Hamburg, Germany.
| |
Collapse
|
3
|
Fetters KB, Fernandez-Hazoury D, Grujic S, Lee P. Disseminated coccidioidomycosis presenting as eosinophilic ascites. BMJ Case Rep 2025; 18:e263734. [PMID: 40234081 DOI: 10.1136/bcr-2024-263734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/17/2025] Open
Abstract
A man in his 50s with a self-reported history of liver cirrhosis was admitted to the hospital for the treatment of suspected spontaneous bacterial peritonitis (SBP). Initial imaging revealed a mildly nodular liver, a large volume of ascites and omental thickening. He was treated empirically for SBP. Ascitic fluid analysis from paracentesis demonstrated eosinophils and a low serum-ascites albumin gradient. He was discharged from the hospital with a diagnosis of peritoneal carcinomatosis pending work-up for an unknown primary malignancy. An extensive malignancy work-up was negative, but an omental biopsy revealed coccidioidomycosis by culture and histopathology. With high-dose fluconazole therapy, his abdominal pain improved, and his ascites completely resolved. Eosinophilia in ascitic fluid is uncommon and should prompt consideration of rare diagnoses, such as peritoneal coccidioidomycosis, tuberculosis, helminthic infections or eosinophilic gastrointestinal diseases.
Collapse
Affiliation(s)
- Kirk Brant Fetters
- Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA
| | | | - Sava Grujic
- Department of Pathology, Harbor-UCLA Medical Center, Torrance, California, USA
| | - Pamela Lee
- Division of Infectious Disease, Harbor-UCLA Medical Center, Torrance, California, USA
- The Lundquist Institute for Biomedical Innovation, Torrance, California, USA
| |
Collapse
|
4
|
Raulf M, Annesi-Maesano I. Occupational allergy and climate change. Curr Opin Allergy Clin Immunol 2025; 25:83-87. [PMID: 39869536 DOI: 10.1097/aci.0000000000001060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2025]
Abstract
PURPOSE OF REVIEW Climate change influences working conditions in various ways, affecting employee health and safety across different sectors. Climatic factors like rising temperatures, increased UV radiation, and more frequent extreme weather events pose risks to in both indoor and outdoor workers. Allergic diseases of the respiratory tract and the skin may emerge due to climate change. This review summarizes current aspects of both direct and indirect consequences of climate change and associated exposures in diverse work environments, focusing on occupational allergies. RECENT FINDINGS Outdoor workers, in particular, are increasing susceptible to ubiquitous pollen allergens. Additionally, they may experience climate-related increases in allergens typically associated with specific workplaces, such as Cryptostroma corticale . Changes in production processes, along with altered workplaces exposures, can lead to new sensitizations and trigger allergies, representing indirect consequences of climate change. Furthermore, lifestyle changes aimed to promoting climate protection and sustainability (e.g. the introduction of insects as a protein source or using enzymes), may also contribute to the emergence of new allergens. SUMMARY The emergence of new occupational sensitization sources from novel or modified allergen exposures must be addressed within the framework of workplace safety and health, necessitating proactive measures to safeguard workers and mitigate risks.
Collapse
Affiliation(s)
- Monika Raulf
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Germany
| | - Isabella Annesi-Maesano
- Department of Pulmonology, Allergy and Thoracic Oncology, University Hospital of Montpellier, Montpellier, France
| |
Collapse
|
5
|
Coleman M, Khan PY, Linde L, Williams PCM, Marais BJ. Transgression of planetary boundaries and the effects on child health through an infectious diseases lens. Curr Opin Pediatr 2025; 37:124-136. [PMID: 39882682 DOI: 10.1097/mop.0000000000001442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2025]
Abstract
PURPOSE OF REVIEW Life on earth, as we know it, is changing. The likelihood of more frequent pandemics and disease outbreaks is something that current global healthcare infrastructure is ill equipped to navigate. Human activity is forcing our planet into a new geologic epoch, the Anthropocene, which is typified by increased uncertainty resulting from human disruption of earth's life-giving ecosystems. Plagues and pandemics have always been unfortunate partners to periods of disruption, as they will be again if the frequency and severity of climate and conflict-mediated disasters increase in coming years. If we continue to exceed and degrade the planetary boundaries that protect human health, our children and their children will reap the consequences. RECENT FINDINGS Scientists have defined nine 'safe operating' planetary boundaries for life in all its glorious diversity to thrive on planet earth. Recent evidence suggests that six of these nine boundaries have already been transgressed, but the potential implications for these transgressions upon child health is not well articulated. We highlight how contravention of these boundaries will impact infectious disease risk and humans' ability to survive and thrive. We reflect specifically on how paediatricians are called upon to speak up for the most vulnerable members of our species, young children and as yet unborn future generations. SUMMARY Post COVID-19 initiatives to improve pandemic preparedness and response are certainly warranted, but pandemic prevention should include committed efforts not to exceed safe planetary boundaries. Willingly exceeding these boundaries has deep moral consequences that are poorly articulated by current ethical frameworks. Paediatricians are best placed to develop and champion the neglected 'third dimension' of medical ethics, recognizing the moral imperative to protect the long-term best interests of children and future generations.
Collapse
Affiliation(s)
- Mikaela Coleman
- Sydney Infectious Diseases Institute (Sydney ID), University of Sydney, Sydney, New South Wales, Australia
- Institute of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University, Munich, Germany
| | - Palwasha Y Khan
- Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK
| | - Lauren Linde
- Boston University School of Public Health, Boston, Massachusetts, USA
| | - Phoebe C M Williams
- Sydney Infectious Diseases Institute (Sydney ID), University of Sydney, Sydney, New South Wales, Australia
- Department of Infectious Diseases, Sydney Children's Hospital
- School of Public Health, Faculty of Medicine, University of Sydney
- Discipline of Paediatrics, School of Clinical Medicine, Faculty of Medicine and Health, UNSW
| | - Ben J Marais
- Sydney Infectious Diseases Institute (Sydney ID), University of Sydney, Sydney, New South Wales, Australia
- WHO Collaborating Centre for Tuberculosis, Sydney, New South Wales, Australia
| |
Collapse
|
6
|
Cao Y, Wu H, Zhang Y, Wu X, Li J, Chen H, Gao W. Time trends in malaria incidence from 1992 to 2021 in high-risk regions: An age‑period‑cohort analysis based on the Global Burden of Disease study 2021. Int J Infect Dis 2025; 153:107770. [PMID: 39736331 DOI: 10.1016/j.ijid.2024.107770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2024] [Revised: 12/22/2024] [Accepted: 12/23/2024] [Indexed: 01/01/2025] Open
Abstract
OBJECTIVES Malaria, caused by plasmodium parasites, remains one of the world's most significant infectious diseases due to its high incidence and mortality. This study aims to analyze malaria incidence globally, identify high-risk regions, and examine long-term trends in incidence to provide important evidence for malaria eradication. METHODS We used data from the Global Burden of Disease Study 2021, applying the age-period-cohort model to estimate the effects of age, period, and cohort on malaria incidence from 1992 to 2021. We calculated the net drift (overall annual percentage change), local drift (annual percentage change for each age group), longitudinal age curves (expected longitudinal age-specific rates), and period (cohort) relative risks. RESULTS In 2021, the global age-standardized incidence rate of malaria declined to 3485.3 per 100,000 (95% uncertainty interval [UI]: 2804.5-4435.7), a 5.24% decrease since 1992. Sub-Saharan Africa has the highest age-standardized rate at 20,225.9 per 100,000 (95% UI: 16,033.5-25,862.6), accounting for 92% of all new cases globally. From 1992 to 2021, age-standardized malaria incidence rates generally declined across highest-risk regions, although Sub-Saharan Africa saw the smallest decline, with a net drift of -0.74% (95% confidence interval: -1.32 to 0.17). The 0-4 age group faces the highest risk, which decreases with age. CONCLUSION Malaria continues to threaten public health in Sub-Saharan Africa, particularly among the 0-4 age group. Efforts should focus on enhancing access to malaria control measures and implementing targeted public health policies for priority groups.
Collapse
Affiliation(s)
- Yu Cao
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Hao Wu
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Yongping Zhang
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Xueyi Wu
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Jingjing Li
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Hanwu Chen
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China
| | - Wei Gao
- Department of Epidemiology & Health Statistics, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang University, Nanchang, China.
| |
Collapse
|
7
|
Réveillon-Istin M, Mondain V, Piednoir E, Diamantis S, Bonnet L, Beaumont AL. Infectious Disease Specialists' awareness, perceptions and attitudes toward ecological transition in healthcare: a cross-sectional study in France. Eur J Clin Microbiol Infect Dis 2025; 44:951-961. [PMID: 39948330 DOI: 10.1007/s10096-025-05064-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2024] [Accepted: 02/05/2025] [Indexed: 03/27/2025]
Abstract
INTRODUCTION Climate change is having a major impact on public health. The healthcare system is responsible for around 8% of greenhouse gas emissions in France. Infectious diseases (ID) lie at the heart of these consequences. OBJECTIVES The primary aim of this study was to assess the expectations of French ID specialists in terms of a sustainable healthcare transition. Secondary objectives included the assessment of awareness regarding this subject, perceptions, adopted attitudes and opportunities for actions. METHODS A survey on sustainable healthcare transition was sent to all the French Society for ID members. RESULTS Of the 860 physicians approached, 220 responded. More than 78% of respondents responded correctly to questions concerning the impact of climate change on public health. The environmental impact of the healthcare system was less well understood. A higher level of environmental anxiety was associated with a higher rate of declaration of concrete actions. People under 40 years of age declared themselves to be more active. Regarding attitudes towards the roles of different stakeholders in a sustainable healthcare transition, the role of medical societies is prominent. Respondents' main expectations and suggestions are the following: (1) creation of a cross functional group dedicated to a sustainable healthcare transition, (2) creation of a training program, to meet the training needs of 94% of respondents, (3) continuation of the French Society for ID's lobbying for the relocation of antibiotic production in Europe, research on life-cycle analysis of anti-infective drugs, single-dose packaging for antibiotics, (4) reflection on the concept of "sustainably designed healthcare" in ID, (5) continued exploration of the "One Health" concept and (6) development of recommendations for sustainably designed hygiene practice. CONCLUSION This national survey of French ID specialists is a prerequisite for the implementation of actions within the French Society for ID.
Collapse
Affiliation(s)
| | | | - Emmanuel Piednoir
- Infectious Disease Unit, Hôpitaux du Sud Manche, Avranches, France
- Normandie Univ, Unicaen, Inserm UMR 1311 DYNAMICURE, Caen, France
| | - Sylvain Diamantis
- Infectious Disease Unit, Groupe Hospitalier Sud Ile de France, Melun, France
| | - Laure Bonnet
- Department of Anaesthesiology and Intensive Care, Centre Hospitalier Princesse Grace de Monaco, Monaco City, Monaco
| | - Anne-Lise Beaumont
- Epidemiology and Modelling of Antibiotic Evasion (EMAE), Institut Pasteur, Université Paris Cité, Paris, France
- Anti-Infective Evasion and Pharmacoepidemiology Team, Université Paris-Saclay, UVSQ, Inserm, Montigny-Le-Bretonneux, France
| |
Collapse
|
8
|
Mulebeke R, Yeka A, van Geertruyden JP. Enhancing malaria elimination in high-transmission settings: the synergy of concurrent vector control and chemotherapy. Malar J 2025; 24:105. [PMID: 40170076 PMCID: PMC11959784 DOI: 10.1186/s12936-025-05339-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Accepted: 03/14/2025] [Indexed: 04/03/2025] Open
Abstract
BACKGROUND Malaria elimination, defined as interrupting local transmission and reducing cases to zero, is a critical public health goal. While a dual parasite-vector approach is essential, the path to elimination is complex and marked by both progress and setbacks. Despite renewed commitment and initiatives like the "High Burden High Impact" approach, challenges persist, particularly in sub-Saharan Africa. These include shifting epidemiological profiles, weak health systems, drug and insecticide resistance, and emerging global issues. Effective elimination, therefore, requires a multi-pronged approach, scaling-up a package of interventions tailored to transmission intensity, including prompt treatment with ACT, IPTp for pregnant women, vector control measures like IRS and LLINs, and robust community engagement. Ultimately, a combination of contextually appropriate strategies, implemented synergistically, will be crucial to breaking the transmission cycle and achieving sustained malaria elimination. This report aims to review the available evidence on the strategies and deployment of current tools targeting vectors and parasites in resource-limited settings, focusing on sub-Saharan Africa. RECENT FINDINGS Combining malaria interventions can create a synergistic effect, where the combined impact is greater than the sum of individual interventions. For example, simulations show benefits from combining MDA and IRS, vaccines and bed nets, or the RTS,S vaccine with perennial malaria chemotherapy. However, synergistic effects are not always guaranteed; some combinations, like LLINs and IRS, may not provide additional benefit. Conversely, combining IRS and MDA, or SMC with seasonal malaria vaccination, has demonstrated increased protective effects. Therefore, successful elimination efforts depend on country-specific factors including malaria burden, political commitment, and health system capacity. However, significant biological and operational challenges remain, which may necessitate contextually appropriate approaches to achieve malaria elimination. CONCLUSION Synergistic intervention effects are crucial, but implementation context is paramount. While combining malaria interventions can be highly effective, not all combinations yield equal results. Thus, tailoring strategies to the specific local context and transmission dynamics is essential for maximizing impact. Moreover, successful malaria elimination is heavily reliant robust health systems and understanding the biological and operational challenges. Consequently, adaptable, evidence-based strategies are required to overcome these obstacles and achieve lasting progress toward malaria elimination.
Collapse
Affiliation(s)
- Ronald Mulebeke
- Global Health Institute, University of Antwerp, Antwerpen, Belgium.
- Makerere University School of Public Health, Kampala, Uganda.
| | - Adoke Yeka
- Makerere University School of Public Health, Kampala, Uganda
| | | |
Collapse
|
9
|
Knoblauch S, Mukaratirwa RT, Pimenta PFP, de A Rocha AA, Yin MS, Randhawa S, Lautenbach S, Wilder-Smith A, Rocklöv J, Brady OJ, Biljecki F, Dambach P, Jänisch T, Resch B, Haddawy P, Bärnighausen T, Zipf A. Urban Aedes aegypti suitability indicators: a study in Rio de Janeiro, Brazil. Lancet Planet Health 2025; 9:e264-e273. [PMID: 40252673 DOI: 10.1016/s2542-5196(25)00049-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2024] [Revised: 02/19/2025] [Accepted: 02/19/2025] [Indexed: 04/21/2025]
Abstract
BACKGROUND Controlling Aedes aegypti stands as the primary strategy in curtailing the global threat of vector-borne viral infections such as dengue fever, which is responsible for around 400 million infections and 40 000 fatalities annually. Effective interventions require a precise understanding of Ae aegypti spatiotemporal distribution and behaviour, particularly in urban settings where most infections occur. However, conventionally applied sample-based entomological surveillance systems often fail to capture the high spatial variability of Ae aegypti that can arise from heterogeneous urban landscapes and restricted Aedes flight range. METHODS In this study, we aimed to address the challenge of capturing the spatial variability of Ae aegypti by leveraging emerging geospatial big data, including openly available satellite and street view imagery, to locate common Ae aegypti breeding habitats. These data enabled us to infer the seasonal suitability for Ae aegypti eggs and larvae at a spatial resolution of 200 m within the municipality of Rio de Janeiro, Brazil. FINDINGS The proposed microhabitat and macrohabitat indicators for immature Ae aegypti explained the distribution of Ae aegypti ovitrap egg counts by up to 72% (95% CI 70-74) and larval counts by up to 74% (72-76). Spatiotemporal interpolations of ovitrap counts, using suitability indicators, provided high-resolution insights into the spatial variability of urban immature Ae aegypti that could not be captured with sample-based surveillance techniques alone. INTERPRETATION The potential of the proposed method lies in synergising entomological field measurements with digital indicators on urban landscape to guide vector control and address the prevailing spread of Ae aegypti-transmitted viruses. Estimating Ae aegypti distributions considering habitat size is particularly important for targeting novel vector control interventions such as Wolbachia. FUNDING German Research Foundation and Austrian Science Fund.
Collapse
Affiliation(s)
- Steffen Knoblauch
- GIScience Research Group, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Interdisciplinary Centre of Scientific Computing, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; HeiGIT, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
| | - Rutendo T Mukaratirwa
- HeiGIT, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Department of Remote Sensing, University of Würzburg, Germany
| | - Paulo F P Pimenta
- Oswaldo Cruz Foundation, René Rachou Research Institute, Belo Horizonte, Brazil
| | | | - Myat Su Yin
- Faculty of ICT, Mahidol University, Nakhon Pathom, Thailand
| | - Sukanya Randhawa
- HeiGIT, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany
| | - Sven Lautenbach
- HeiGIT, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany
| | | | - Joacim Rocklöv
- Interdisciplinary Centre of Scientific Computing, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden
| | - Oliver J Brady
- Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology and Dynamics, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK; Centre on Climate Change and Planetary Health, London School of Hygiene & Tropical Medicine, London, UK
| | - Filip Biljecki
- Department of Architecture, National University of Singapore, Singapore; Department of Real Estate, National University of Singapore, Singapore
| | - Peter Dambach
- Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany
| | - Thomas Jänisch
- Center for Global Health and Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA
| | - Bernd Resch
- Interdisciplinary Transformation University Austria, Linz, Austria; Center for Geographic Analysis, Harvard University, Cambridge, MA, USA
| | - Peter Haddawy
- Faculty of ICT, Mahidol University, Nakhon Pathom, Thailand; Bremen Spatial Cognition Center, University of Bremen, Bremen, Germany
| | - Till Bärnighausen
- Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Department of Global Health and Population, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA; Africa Health Research Institute, Durban, South Africa
| | - Alexander Zipf
- GIScience Research Group, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Interdisciplinary Centre of Scientific Computing, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; HeiGIT, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany
| |
Collapse
|
10
|
Viennet E, Dean MM, Kircher J, Leder K, Guo Y, Jones P, Faddy HM. Blood under pressure: how climate change threatens blood safety and supply chains. Lancet Planet Health 2025; 9:e304-e313. [PMID: 40252677 DOI: 10.1016/s2542-5196(25)00051-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2024] [Revised: 02/20/2025] [Accepted: 02/20/2025] [Indexed: 04/21/2025]
Abstract
Climate change substantially threatens public health, including the blood supply chain, which is crucial for medical treatments such as surgeries, trauma care, and chronic disease management. Extreme weather events, vector-borne disease shifts, and temperature fluctuations can disrupt blood collection, testing, transport, and storage, threatening both the safety and sufficiency of blood products. Although studies have highlighted some connections between climate change, transfusion-transmissible infections, and blood safety, there remains a lack of comprehensive understanding of the climate effects on each supply chain stage. In this Personal View, we address the potential climate-driven challenges across the blood supply chain, from donor health to blood component stability, emphasising the importance of proactive measures. To protect the availability and safety of blood supplies in an evolving climate, further research and adaptive strategies are needed to build a resilient blood supply system that can withstand emerging climate-related disruptions.
Collapse
Affiliation(s)
- Elvina Viennet
- Research and Development, Australian Red Cross Lifeblood, Brisbane, QLD, Australia; Centre for Immunology and Infection Control, Queensland University of Technology, Brisbane, QLD, Australia; School of Health, University of the Sunshine Coast, Petrie, QLD, Australia.
| | - Melinda M Dean
- Research and Development, Australian Red Cross Lifeblood, Brisbane, QLD, Australia; School of Health, University of the Sunshine Coast, Petrie, QLD, Australia
| | - Jorga Kircher
- School of Health, University of the Sunshine Coast, Petrie, QLD, Australia
| | - Karin Leder
- School of Public Health and Preventive Medicine, Planetary Health Division, Monash University, Melbourne, VIC, Australia; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, VIC, Australia
| | - Yuming Guo
- School of Public Health and Preventive Medicine, Planetary Health Division, Monash University, Melbourne, VIC, Australia
| | - Phoebe Jones
- Research and Development, Australian Red Cross Lifeblood, Brisbane, QLD, Australia
| | - Helen M Faddy
- Research and Development, Australian Red Cross Lifeblood, Brisbane, QLD, Australia; School of Health, University of the Sunshine Coast, Petrie, QLD, Australia
| |
Collapse
|
11
|
Lyberger K, Robinson AR, Couper L, Delwel I, Glidden C, Qian C, Burslem A, Fernandez F, Gao B, Garcia G, Gomez J, Griffin C, Jackson S, King A, Manes O, Song A, Tran E, Mordecai EA. A systematic review of climate-change driven range shifts in mosquito vectors. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2025:2025.03.25.645279. [PMID: 40196676 PMCID: PMC11974840 DOI: 10.1101/2025.03.25.645279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/09/2025]
Abstract
As global temperatures rise, concerns about shifting mosquito ranges-and accompanying changes in the transmission of malaria, dengue, and other diseases-are mounting. However, systematic evidence for climate-driven changes in mosquito ranges remains limited. We conducted a systematic review of studies documenting expansions or contractions in medically important mosquito species. In total, 178 studies on six continents identified range expansions in 118 mosquito species. While over a third of these studies cited warming as a driver, fewer than 10% performed statistical tests of the role of climate. Instead, most expansions were linked to human-aided dispersal (e.g., trade, travel), land-use changes, and urbanization. Although several studies reported poleward or upward expansions consistent with climate warming, none demonstrated warm-edge contractions driven by rising temperatures, which are theoretically predicted in some settings. Rather than expanding into newly suitable areas, many expansions appear to be filling preexisting thermally suitable habitats. Our findings highlight the need for long-term mosquito monitoring, rigorous climate-attribution methods, and better documentation of confounding factors like land-use change and vector control efforts to disentangle climate-driven changes from other anthropogenic factors.
Collapse
Affiliation(s)
- Kelsey Lyberger
- College of Integrative Sciences and Arts, Arizona State University, Mesa, AZ
| | | | - Lisa Couper
- School of Public Health, Division of Environmental Health Sciences, University of California, Berkeley
| | - Isabel Delwel
- Department of Biology, Stanford University, Stanford, CA
| | | | - Crystal Qian
- Department of Biology, Stanford University, Stanford, CA
| | - Aja Burslem
- Department of Biology, Stanford University, Stanford, CA
| | | | - Benjamen Gao
- Department of Biology, Stanford University, Stanford, CA
| | | | - Julio Gomez
- Department of Biology, Stanford University, Stanford, CA
| | - Caspar Griffin
- Department of Biology, Stanford University, Stanford, CA
| | | | - Annalisa King
- Department of Biology, Stanford University, Stanford, CA
| | - Olivia Manes
- Department of Biology, Stanford University, Stanford, CA
| | - Andrew Song
- Department of Biology, Stanford University, Stanford, CA
| | - Edward Tran
- Department of Biology, Stanford University, Stanford, CA
| | | |
Collapse
|
12
|
Wrench A, Vélez-Figueroa AC, de Lamadrid JJRG, Pommells K, Sánchez JP. Diseases Transmitted by Arthropods: Module to Train Medical Providers in English and Spanish. MEDEDPORTAL : THE JOURNAL OF TEACHING AND LEARNING RESOURCES 2025; 21:11509. [PMID: 40135104 PMCID: PMC11934777 DOI: 10.15766/mep_2374-8265.11509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Accepted: 01/30/2025] [Indexed: 03/27/2025]
Abstract
Introduction Arthropod-borne diseases like Chagas, dengue, and West Nile virus are common among migrants and immigrants from Spanish-speaking countries and U.S. travelers. The U.S. Census Bureau predicts that by 2060, 28% of the total U.S. population and 39% of the foreign-born population will be Hispanic. Health care practitioners need a thorough understanding of these diseases to provide proper care and improve patient compliance for the ever-changing U.S. population. Methods We used Kern's model to develop an hour-long interactive module consisting of a presentation, a video for large-group discussion, six case studies for small-group discussions, and pre- and postsession evaluations. All materials are available in English and Spanish; the module is tailored to health care providers communicating with Spanish-speaking patients. We used statistical tests to compare confidence levels and assess improvements in knowledge before and after the module. Results The module was implemented three times in Spanish and two times in English to a total of 49 participants, which included prehealth students, medical students, graduate students, and faculty/staff. The Wilcoxon rank sum test demonstrated significant improvement from pre- to postsession evaluations for all educational objectives. Based on a 5-point Likert scale, the median confidence level increased from 2 (slightly confident) to 4 (fairly confident), with p < .01. Discussion This module can be of particular importance to health care providers localized in or focused on Hispanic communities. It can be easily integrated into microbiology, epidemiology, and medical Spanish courses. Further research is needed to assess its effectiveness among faculty and staff.
Collapse
Affiliation(s)
- Algevis Wrench
- Associate Professor, Department of Medicine, Dr. Kiran C. Patel College of Allopathic Medicine
| | - Andrea Celeste Vélez-Figueroa
- First-Year Resident, Hospital Universitario Dr. Ramón Ruiz Arnau and Universidad Central del Caribe School of Medicine
| | | | - Kaitlyn Pommells
- Coordinator, Academic Medicine Writing Fellowship, Building the Next Generation of Academic Physicians
| | - John Paul Sánchez
- Dean, School of Medicine, Universidad Central del Caribe School of Medicine
| |
Collapse
|
13
|
Yenew C, Bayeh GM, Gebeyehu AA, Enawgaw AS, Asmare ZA, Ejigu AG, Tsega TD, Temesgen A, Anteneh RM, Yigzaw ZA, Yirdaw G, Tsega SS, Ahmed AF, Yeshiwas AG. Scoping review on assessing climate-sensitive health risks. BMC Public Health 2025; 25:914. [PMID: 40055611 PMCID: PMC11887272 DOI: 10.1186/s12889-025-22148-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2024] [Accepted: 02/28/2025] [Indexed: 05/13/2025] Open
Abstract
BACKGROUND Climate change is making the existing health problems worse and also introducing new health problem and therefore calls for a wider evaluation of climate sensitive global diseases. The review sought to assess and collate quantitative and qualitative evidence on the effects of climate change on global health, more specifically, infectious and respiratory diseases, the impacts of extreme weather events as well as the implications for mental health with the view of establishing appropriate sustainable and resilience public health measures and policies. METHODOLOGY A scoping review of observational studies carried out between the years 2000 and 2024, synthesized information on climate-sensitive health outcomes: infectious diseases, severe weather events, and mental illnesses. This analysis was based on data from PubMed, Scopus, Web of Science and Cochrane Library, where appropriate, utilizing meta-extraction and Meta-analysis techniques. RESULTS A total of 3077 studies were screened, and 96 articles were included for quantitative and qualitative analysis, highlighting the significant health risks posed by climate change. Key areas of concern identified include climate-sensitive infectious diseases, respiratory and cardiovascular conditions, food- and water-borne illnesses, and mental health effects. Rising temperatures and variable rainfall patterns increase the incidence of diseases like malaria (up to 50%) and dengue (8-10% per 1 °C rise). Extreme weather events, such as heatwaves and floods, contribute to a 30% rise in respiratory diseases and a 25% increase in cardiovascular conditions. Food- and water-borne illnesses are more prevalent in regions like Africa (30-40%) due to climate change. Additionally, climate change exacerbates mental health issues, leading to conditions like post-traumatic stress disorder (PTSD), anxiety, and depression. CONCLUSION AND RECOMMENDATIONS Climate change amplifies global public health risks, worsening diseases and creating new challenges. To address this, enhance machine learning climate sensitive disease surveillance, strengthen climate resilience health infrastructure, and integrate health into climate adaptation and mitigation strategies, promote sustainable agriculture, improve WASH infrastructure, and foster global collaboration.
Collapse
Affiliation(s)
- Chalachew Yenew
- Department of Environmental Health Sciences, Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
| | - Gashaw Melkie Bayeh
- Department of Environmental Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia
| | - Asaye Alamneh Gebeyehu
- Depatment of Public Health, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia
| | - Anley Shiferaw Enawgaw
- Department of Public Health, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia
| | - Zufan Alamrie Asmare
- Department of Ophthalmology, School of Medicine and Health Science, Debre Tabor University, Debre Tabor, Ethiopia
| | - Amare Genetu Ejigu
- Department of Midwifery, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia
| | - Tilahun Degu Tsega
- Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia
| | - Abathun Temesgen
- Department of Environmental Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia
| | - Rahel Mulatie Anteneh
- Depatment of Public Health, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia
| | - Zeamanuel Anteneh Yigzaw
- Department of Health Promotion and Behavioral Sciences, School of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia
| | - Getasew Yirdaw
- Department of Environmental Health Science, College of Medicine and Health Sciences, Debre Markos University, Debre Markos, Ethiopia
| | - Sintayehu Simie Tsega
- Department of Medical Nursing, School of Nursing, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia
| | - Ahmed Fentaw Ahmed
- Department of Public Health, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia
| | - Almaw Genet Yeshiwas
- Department of Environmental Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia
| |
Collapse
|
14
|
Muniz VA, de Melo Katak R, Caesar L, de Oliveira JC, Rocha EM, de Oliveira MR, da Silva GF, Roque RA, Marinotti O, Terenius O, de Andrade EV. Genomic and morphological features of an Amazonian Bacillus thuringiensis with mosquito larvicidal activity. AMB Express 2025; 15:39. [PMID: 40045023 PMCID: PMC11882490 DOI: 10.1186/s13568-025-01850-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2024] [Accepted: 02/18/2025] [Indexed: 03/09/2025] Open
Abstract
The occurrence of mosquito-borne diseases is increasing, and their geographical range is expanding due to climate change. New control measures are urgently needed to combat these debilitating and, in some cases, fatal diseases. Bacteria of the genus Bacillus are of interest due to the production of bioactive compounds, including those useful for insect control. The discovery and characterization of new species of Bacillus with mosquito larvicidal activity may offer opportunities to develop new products for vector control. In this study, we evaluated larvicidal activity, described morphological characteristics, and sequenced and analyzed the genome of a bacterial strain (GD02.13) isolated from the Amazon region. The metabolites produced by GD02.13 are as effective in killing Aedes aegypti larvae as the commercial product Natular™ DT (Spinosad). Furthermore, the morphological characteristics of the GD02.13 spores and crystal inclusions resemble those previously described for B. thuringiensis. A phylogenetic analysis based on 443 single-copy orthologs indicated that the bacterial strain GD02.13 belongs to the Bacillus thuringiensis species. Its genome, which was assembled and has a size of 6.6 Mb, contains 16 secondary metabolite biosynthetic gene clusters and genes encoding insecticidal proteins, predicted based on sequence similarity. The data obtained in this study support the development of new insecticide products based on the strain GD02.13 of B. thuringiensis.
Collapse
Affiliation(s)
| | - Ricardo de Melo Katak
- Oswaldo Cruz Foundation - Leônidas and Maria Deane Institute, Manaus, Amazonas, Brazil
| | - Lílian Caesar
- Department of Biology, Indiana University, Bloomington, IN, 47405, USA
| | | | | | - Marta Rodrigues de Oliveira
- Department of Entomology and Acarology, Luiz de Queiroz College of Agriculture, University of São Paulo, ESALQ - USP - Piracicaba, São Paulo, Brazil
| | | | | | - Osvaldo Marinotti
- Department of Biology, Indiana University, Bloomington, IN, 47405, USA
| | - Olle Terenius
- Department of Cell and Molecular Biology, Uppsala University, P.O. Box 596, 751 24, Uppsala, Sweden.
| | | |
Collapse
|
15
|
Viberg A, Byström B. Frequency and Outcome of Emergency Penetrating Keratoplasty in Infectious Keratitis in Sweden During the 21st Century. Cornea 2025; 44:305-310. [PMID: 39903443 DOI: 10.1097/ico.0000000000003638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Accepted: 06/19/2024] [Indexed: 07/27/2024]
Abstract
PURPOSE To study the frequency over time and outcome of penetrating keratoplasty (PK), "keratoplasty à chaud," in patients with infectious keratitis with 2-year follow-up data. METHODS This register-based study included keratitis cases that had undergone PK in Sweden between 2001 and 2020 and reported to the Swedish Corneal Transplant Register. RESULTS During the study period, 69 eyes were subjected to acute PK due to progressive infectious keratitis. The number increased from 2 annual procedures in the first half of the study period to 5 in the second half ( P = 0.01). Preoperative corneal perforation was present in 43.5% (n = 30) of the eyes. Two years after surgery, follow-up data were completed in the register for 53 eyes; of these, 62.3% (n = 33) were considered to have functioning grafts, and 20.8% (n = 11) had experienced a rejection episode. The visual acuity improved from hand motion to counting fingers ( P = 0.002), and the proportion of eyes with a visual acuity of ≤1.0 logMAR increased from 5.7% (n = 3) before the surgery to 45.3% (n = 24) at the 2-year follow-up ( P < 0.001). CONCLUSIONS The number of active infectious keratitis cases undergoing keratoplasty à chaud increased in Sweden during the 21st century. Most of the cases were successful regarding the structural integrity of the bulb, that is, "had a saved eye" and even a functioning graft 2 years after corneal transplantation. The visual gain was distinct, albeit modest. In cases with severe infectious keratitis, and even a concomitant perforation in the cornea due to the infection, corneal transplantation should continue to be an option.
Collapse
Affiliation(s)
- Andreas Viberg
- Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden
| | | |
Collapse
|
16
|
Liang T, Ai Z, Zhong H, Xiao M, Xie M, Liang X, Li L. The impact of temperature changes on the health vulnerability of migrant workers: an empirical study based on the China family panel studies. Front Public Health 2025; 13:1519982. [PMID: 40078768 PMCID: PMC11897529 DOI: 10.3389/fpubh.2025.1519982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2024] [Accepted: 01/24/2025] [Indexed: 03/14/2025] Open
Abstract
Introduction Migrant workers constitute a significant portion of China's workforce, and their health directly affects labor supply and economic stability. Health vulnerability plays a crucial role in shaping the well-being of migrant workers, yet its determinants, particularly the impact of temperature change, remain underexplored. This study, based on the socio-ecological model, investigates how temperature variations influence the health vulnerability of migrant workers in China. Methods Using data from 2020, this study quantifies health vulnerability and examines the impact of temperature fluctuations across different seasons. Robustness checks, including dependent variable substitutions and model modifications, ensure the reliability of the findings. Furthermore, a mechanism analysis is conducted to explore the underlying pathways through which temperature change affects health vulnerability. Results The findings reveal that rising temperatures in spring, summer, and winter significantly exacerbate the health vulnerability of migrant workers, while increasing autumn temperatures mitigate it. Mechanism analysis identifies heightened psychological burden as a key channel through which temperature change worsens health vulnerability. Additionally, generational differences emerge: older migrant workers are more adversely affected by elevated spring temperatures, whereas younger workers exhibit greater sensitivity to rising summer temperatures. Discussion These results underscore the necessity of targeted health interventions and adaptive labor protection policies. By highlighting the seasonal and generational disparities in the effects of temperature change, this study offers theoretical and empirical support for enhancing the resilience of migrant workers to climate variations. The findings provide valuable insights for policymakers in designing strategies to safeguard the health and stability of the migrant workforce.
Collapse
Affiliation(s)
- Ting Liang
- School of Chinese Medicine, Hunan Brain Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
- Hunan Engineering Technology Research Center for Medicinal and Functional Food, Changsha, Hunan, China
- Key Laboratory of TCM Heart and Lung Syndrome Differentiation & Medicated Diet and Dietotherapy, Changsha, Hunan, China
| | - Zilin Ai
- Department of Political Science and Public Administration, Guangxi Normal University, Guilin, Guangxi, China
| | - Hui Zhong
- School of Dental Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China
| | - Mengyan Xiao
- School of Chinese Medicine, Hunan Brain Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
- Hunan Engineering Technology Research Center for Medicinal and Functional Food, Changsha, Hunan, China
- Key Laboratory of TCM Heart and Lung Syndrome Differentiation & Medicated Diet and Dietotherapy, Changsha, Hunan, China
| | - Mengzhou Xie
- School of Chinese Medicine, Hunan Brain Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
- Hunan Engineering Technology Research Center for Medicinal and Functional Food, Changsha, Hunan, China
- Key Laboratory of TCM Heart and Lung Syndrome Differentiation & Medicated Diet and Dietotherapy, Changsha, Hunan, China
| | - Xiaoli Liang
- School of Chinese Medicine, Hunan Brain Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
| | - Liang Li
- School of Chinese Medicine, Hunan Brain Hospital, Hunan University of Chinese Medicine, Changsha, Hunan, China
- Hunan Engineering Technology Research Center for Medicinal and Functional Food, Changsha, Hunan, China
- Key Laboratory of TCM Heart and Lung Syndrome Differentiation & Medicated Diet and Dietotherapy, Changsha, Hunan, China
| |
Collapse
|
17
|
Francian A, Flores-Garcia Y, Powell JR, Petrovsky N, Zavala F, Chackerian B. Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein TRIO. mSphere 2025; 10:e0079824. [PMID: 39878467 PMCID: PMC11852919 DOI: 10.1128/msphere.00798-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2024] [Accepted: 01/14/2025] [Indexed: 01/31/2025] Open
Abstract
Malaria is a highly lethal infectious disease caused by Plasmodium parasites. These parasites are transmitted to vertebrate hosts when mosquitoes of the Anopheles genus probe for a blood meal. Sporozoites, the infectious stage of Plasmodium, transit to the liver within hours of injection into the dermis. Vaccine efforts are hindered by the complexity of the parasite's lifecycle and the speed at which the infection is established in the liver. In an effort to enhance immunity against Plasmodium, we produced a virus-like particle (VLP)-based vaccine displaying an epitope of TRIO, an Anopheles salivary protein that has been shown to enhance mobility and dispersal of sporozoites in the dermis. Previous work demonstrated that passive immunization with TRIO offered protection from liver infection and acted synergistically with a Plasmodium-targeted vaccine. Immunization of mice with TRIO VLPs resulted in high-titer and long-lasting antibody responses that did not significantly drop for over 18 months post-immunization. TRIO VLPs were similarly immunogenic when combined with an anti-malaria vaccine targeting the L9 epitope of the Plasmodium falciparum circumsporozoite protein. However, when used in a malaria challenge mouse model, TRIO VLPs only provided modest protection from infection and did not boost the protection provided by L9 VLPs.IMPORTANCEProteins present in the salivary glands of mosquitos have been shown to enhance the transmission efficiency of mosquito-borne pathogens, suggesting that interventions targeting the activity of these proteins could reduce transmission. Here, we looked at the efficacy of a vaccine targeting TRIO, an Anopheles mosquito salivary protein that has been reported to enhance Plasmodium falciparum malaria infection. We show that this vaccine can elicit strong anti-TRIO antibody responses, but these antibodies only result in a modest decrease in infection.
Collapse
Affiliation(s)
- Alexandra Francian
- Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
| | - Yevel Flores-Garcia
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - John R. Powell
- Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
| | | | - Fidel Zavala
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
| | - Bryce Chackerian
- Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
| |
Collapse
|
18
|
Shen Z, Luo H. The impact of schistosomiasis on the Global Disease Burden: a systematic analysis based on the 2021 Global Burden of Disease study. Parasite 2025; 32:12. [PMID: 39981999 PMCID: PMC11843987 DOI: 10.1051/parasite/2025005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2024] [Accepted: 01/27/2025] [Indexed: 02/22/2025] Open
Abstract
Schistosomiasis is a neglected tropical disease that causes a significant global burden. The aim of this study was to report the latest estimates of the global, regional, and national schistosomiasis disease burden and forecast changes in schistosomiasis-related disease burden. This work was based on the 2021 Global Burden of Disease (GBD) study. We analyzed the schistosomiasis data by sex, age in years, and Socio-Demographic Index (SDI) region and country, using Age-Standardized Rates (ASR) for comparisons among different groups. The Estimated Annual Percent Changes (EAPC) analysis was used to evaluate the temporal trend of the disease burden, and the Differential Autoregressive Integrated Moving Average (ARIMA) and Exponential Smoothing (ES) models were used to predict the disease burden from 2022 to 2046. In the GBD 2021 study, it was reported that compared to 1990, the number of deaths has decreased by 74,350, the prevalence number has increased by 1,482,260, and Disability-Adjusted Life Years (DALYs) have decreased by 1,770,436. Additionally, the age-standardized mortality rate (ASMR) has decreased by 0.31 per 100,000 people, with an EAPC of -0.353 (95% CI: -0.361 to -0.344). Similarly, the age-standardized DALYs rate (ASDR) has decreased by 15.45 per 100,000 people (EAPC: -1.56, 95% CI: -1.78 to -1.34), and the age-standardized prevalence rate (ASPR) has decreased by 559.64 per 100,000 people (EAPC: -0.63, 95% CI: -0.95 to -0.31). The regions and countries with the highest disease burden are mostly concentrated in Africa. Despite a general decline in global schistosomiasis burden indicators, the burden of disease has actually increased in high SDI areas. The ARIMA and ES models forecast results show that female mortality and ASMR will decline in the next 25 years, while male mortality and ASMR will remain stable, and other disease indicators will continue to decline. The global schistosomiasis burden has significantly decreased over the past 30 years, but it remains high in African regions and countries, as well as low-SDI areas. Effective cooperation among countries should be strengthened to improve the disease burden in high-burden areas and countries.
Collapse
Affiliation(s)
- Zhangzhou Shen
- Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention, Hubei Polytechnic University, Medical School Huangshi 435003 Hubei China
| | - Houqiang Luo
- College of Animal Science, Wenzhou Vocational College of Science and Technology Wenzhou 325006 Zhejiang China
| |
Collapse
|
19
|
Agache I, Hernandez ML, Radbel JM, Renz H, Akdis CA. An Overview of Climate Changes and Its Effects on Health: From Mechanisms to One Health. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2025; 13:253-264. [PMID: 39725316 DOI: 10.1016/j.jaip.2024.12.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Revised: 12/13/2024] [Accepted: 12/14/2024] [Indexed: 12/28/2024]
Abstract
Human activities, primarily the burning of fossil fuels, widespread deforestation, soil erosion or machine-intensive farming methods, manufacturing, food processing, mining, construction, and the iron, cement, steel, and chemicals industries, have been the main drivers of the observed increase in Earth's average surface temperature and climate change. Rising global temperatures, extreme weather events, ecosystems disruption, agricultural impacts, water scarcity, problems in access to good quality water, food and housing, and profound environmental disruptions such as biodiversity loss and extreme pollution are expected to steeply increase the prevalence and severity of acute and chronic diseases. Its long-term effects cannot be adequately predicted or mitigated without a comprehensive understanding of the adaptive ecosystems. Studying the complex interaction between environmental aggressors and the resilient adaptive responses requires the exposomic and the One Health approaches. The problem is broad and affects the whole ecosystem, plants, pets, and animals in addition to humans. The central role of the epithelial barrier, microbiome, and diet as key pillars for an adaptive tolerogenic immune response should be explored for increasing resilience at the individual level. A radical change in mindset worldwide, with sustainable solutions and adaptive strategies and climate resilience and health equity policies at their center, should be achieved quickly through increased awareness based on solid scientific data.
Collapse
Affiliation(s)
- Ioana Agache
- Faculty of Medicine, Transylvania University, Brasov, Romania.
| | - Michelle L Hernandez
- Division of Allergy and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC; Children's Research Institute, University of North Carolina, Chapel Hill, NC
| | - Jared M Radbel
- Division of Pulmonary and Critical Care Medicine, Rutgers Robert Wood Johnson University, New Brunswick, NJ
| | - Harald Renz
- Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL) and the Lung Centre of the Universities of Giessen and Marburg (UGMLC), Philipps University Marburg, Marburg, Germany; Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania
| | - Cezmi A Akdis
- Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland
| |
Collapse
|
20
|
Komarudin AG, Adharis A, Sasmono RT. Natural Compounds and Their Analogs as Antivirals Against Dengue Virus: A Review. Phytother Res 2025; 39:888-921. [PMID: 39697048 DOI: 10.1002/ptr.8408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2023] [Revised: 09/23/2024] [Accepted: 09/26/2024] [Indexed: 12/20/2024]
Abstract
Dengue virus (DENV) continues to pose a significant global health challenge, causing diseases such as dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. While efforts in vaccine development and antiviral drug discovery are ongoing, effective therapeutic options remain limited. In this review, we highlight natural compounds and the analogs that demonstrated antiviral activity against DENV in in vitro and in vivo studies. Specifically, these studies examine alkaloids, phenolic acids, phenols, flavonoids, terpenoids, and glycosides which have shown potential in inhibiting DENV entry, replication, and reducing the cytokine storm. By focusing on these bioactive compounds and the analogs, a comprehensive overview of their promising roles is provided to advance therapeutic strategies for combating DENV infection.
Collapse
Affiliation(s)
- Amalina Ghaisani Komarudin
- Eijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Kabupaten Bogor, Jawa Barat, Indonesia
| | - Azis Adharis
- Department of Chemistry, Faculty of Science and Computer Science, Universitas Pertamina (UPER), Jakarta, Indonesia
| | - R Tedjo Sasmono
- Eijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Kabupaten Bogor, Jawa Barat, Indonesia
| |
Collapse
|
21
|
Worsley-Tonks KEL, Angwenyi S, Carlson C, Cissé G, Deem SL, Ferguson AW, Fèvre EM, Kimaro EG, Kimiti DW, Martins DJ, Merbold L, Mottet A, Murray S, Muturi M, Potter TM, Prasad S, Wild H, Hassell JM. A framework for managing infectious diseases in rural areas in low- and middle-income countries in the face of climate change-East Africa as a case study. PLOS GLOBAL PUBLIC HEALTH 2025; 5:e0003892. [PMID: 39883787 PMCID: PMC11781624 DOI: 10.1371/journal.pgph.0003892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2025]
Abstract
Climate change is having unprecedented impacts on human health, including increasing infectious disease risk. Despite this, health systems across the world are currently not prepared for novel disease scenarios anticipated with climate change. While the need for health systems to develop climate change adaptation strategies has been stressed in the past, there is no clear consensus on how this can be achieved, especially in rural areas in low- and middle-income countries that experience high disease burdens and climate change impacts simultaneously. Here, we highlight the need to put health systems in the context of climate change and demonstrate how this can be achieved by taking into account all aspects of infectious disease risk (i.e., pathogen hazards, and exposure and vulnerability to these pathogen hazards). The framework focuses on rural communities in East Africa since communities in this region experience climate change impacts, present specific vulnerabilities and exposure to climate-related hazards, and have regular exposure to a high burden of infectious diseases. Implementing the outlined approach can help make health systems climate adapted and avoid slowing momentum towards achieving global health grand challenge targets.
Collapse
Affiliation(s)
- Katherine E. L. Worsley-Tonks
- Lyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France
- Global Health Program, Smithsonian Conservation Biology Institute, Washington, DC, United States of America
- International Livestock Research Institute, Nairobi, Kenya
| | - Shaleen Angwenyi
- Global Health Program, Smithsonian Conservation Biology Institute, Washington, DC, United States of America
| | - Colin Carlson
- Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, United State of America
| | - Guéladio Cissé
- Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
- Faculty of Science, University of Basel, Basel, Switzerland
| | - Sharon L. Deem
- Institute for Conservation Medicine, Saint Louis Zoo, Saint Louis, Missouri, United States of America
| | - Adam W. Ferguson
- Gantz Family Collection Center, Field Museum of Natural History, Chicago, Illinois, United States of America
| | - Eric M. Fèvre
- International Livestock Research Institute, Nairobi, Kenya
- Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom
| | - Esther G. Kimaro
- Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania
| | | | - Dino J. Martins
- Turkana Basin Institute, Stony Brook University, Stony Brook, New York, United States of America
| | - Lutz Merbold
- Mazingira Centre, International Livestock Research Institute, Nairobi, Kenya
- Integrative Agroecology Group, Research Division Agroecology and Environment, Agroscope, Zurich, Switzerland
| | - Anne Mottet
- International Fund for Agricultural Development; Sustainable Production, Markets and Institutions Division, Rome, Italy,
| | - Suzan Murray
- Global Health Program, Smithsonian Conservation Biology Institute, Washington, DC, United States of America
| | - Mathew Muturi
- Global Health Program, Smithsonian Conservation Biology Institute, Washington, DC, United States of America
- Kenya Zoonotic Disease Unit, Nairobi, Kenya
- Department of Veterinary Medicine, Dahlem Research School of Biomedical Sciences (DRS), Freie Universität Berlin, Berlin, Germany
| | - Teddie M. Potter
- School of Nursing, University of Minnesota, Minneapolis, Minnesota, United States of America
| | - Shailendra Prasad
- Center for Global Health and Social Responsibility, University of Minnesota, Minneapolis, Minnesota, United States of America
| | - Hannah Wild
- Department of Surgery, University of Washington, Seattle, Washington, United States of America
| | - James M. Hassell
- Global Health Program, Smithsonian Conservation Biology Institute, Washington, DC, United States of America
- International Livestock Research Institute, Nairobi, Kenya
- Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, United State of America
| |
Collapse
|
22
|
French S, Da Silva R, Storm J, Wastika CE, Cullen I, Have MT, Hughes GL, Modahl CM. Exploiting venom toxins in paratransgenesis to prevent mosquito-borne disease. Parasit Vectors 2025; 18:32. [PMID: 39881388 PMCID: PMC11776213 DOI: 10.1186/s13071-025-06663-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2024] [Accepted: 01/07/2025] [Indexed: 01/31/2025] Open
Abstract
Mosquitoes are responsible for the transmission of numerous pathogens, including Plasmodium parasites, arboviruses and filarial worms. They pose a significant risk to public health with over 200 million cases of malaria per annum and approximately 4 billion people at risk of arthropod-borne viruses (arboviruses). Mosquito populations are geographically expanding into temperate regions and their distribution is predicted to continue increasing. Mosquito symbionts, including fungi, bacteria and viruses, have desirable traits for mosquito disease control including spreading horizontally and vertically through mosquito populations and potentially colonising multiple important vector species. Paratransgenesis, genetic modification of mosquito symbionts with effectors to target the pathogen rather than the vector, is a promising strategy to prevent the spread of mosquito-borne diseases. A variety of effectors can be expressed but venom toxins are excellent effector candidates because they are target specific, potent and stable. However, the only toxins to be explored in mosquito paratransgenesis to date are scorpine and mutated phospholipase A2. To enhance the scope, effectiveness and durability of paratransgenesis, an expanded arsenal of effectors is required. This review discusses other potential toxin effectors for future paratransgenesis studies based on prior in vitro and in vivo antiparasitic and antiviral studies and highlights the need for further research and investment in this area. In terms of mosquito-borne diseases, paratransgenesis strategies have been developed to target Plasmodium. We postulate the potential to apply this principle to target arboviruses using antiviral toxin effectors.
Collapse
Affiliation(s)
- Stephanie French
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK.
| | - Rachael Da Silva
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Janet Storm
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Christida E Wastika
- Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool, UK
| | - India Cullen
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Martijn Ten Have
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Grant L Hughes
- Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Cassandra M Modahl
- Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, UK
- Departments of Vector Biology and Tropical Disease Biology, Centre for Neglected Tropical Disease, Liverpool School of Tropical Medicine, Liverpool, UK
| |
Collapse
|
23
|
Kisambale AJ, Pereus D, Mandai SS, Lyimo BM, Bakari C, Chacha GA, Mbwambo RB, Moshi R, Petro DA, Challe DP, Seth MD, Madebe RA, Budodo R, Aaron S, Mbwambo D, Lusasi A, Kajange S, Lazaro S, Kapologwe N, Mandara CI, Ishengoma DS. Genetic diversity of Plasmodium falciparum reticulocyte binding protein homologue-5, which is a potential malaria vaccine candidate: baseline data from areas of varying malaria endemicity in Mainland Tanzania. Malar J 2025; 24:29. [PMID: 39871346 PMCID: PMC11773767 DOI: 10.1186/s12936-025-05269-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2024] [Accepted: 01/21/2025] [Indexed: 01/30/2025] Open
Abstract
BACKGROUND The limited efficacy of the two recently approved malaria vaccines, RTS,S/AS01 and R21/Matrix- M™, highlights the need for alternative vaccine candidate genes. Plasmodium falciparum Reticulocyte Binding Protein Homologue 5 (Pfrh5) is a promising malaria vaccine candidate, given its limited polymorphism, its essential role in parasite survival, a lack of immune selection pressure and higher efficacy against multiple parasites strains. This study evaluated the genetic diversity of Pfrh5 gene among parasites from regions with varying malaria transmission intensities in Mainland Tanzania, to generate baseline data for this potential malaria vaccine candidate. METHODS This study utilized secondary data of 697 whole-genome sequences which were generated by the MalariaGEN Community Network. The samples which were sequenced to generated the data were collected between 2010 and 2015 from five districts within five regions of Mainland Tanzania, with varying endemicities (Morogoro-urban district in Morogoro region, Muheza in Tanga, Kigoma-Ujiji in Kigoma, Muleba in Kagera, and Nachingwea district in Lindi region). Wright's fixation index (FST), Wright's inbreeding coefficient (Fws), Principal component analysis (PCA), nucleotide diversity (π), haplotype network, haplotype diversity (Hd), Tajima's D, and Linkage disequilibrium (LD) were used to assess the diversity of the gene. RESULTS Of the sequences used in this study, 84.5% (n = 589/697) passed quality control and 313 (53.1%) were monoclonal (contained infections from a single strain of P. falciparum) and were used for haplotype diversity and haplotype network analysis. High within-host diversity (Fws < 0.95) was reported in Kigoma-Ujiji (60.7%), Morogoro-urban (53.1%), and Nachingwea (50.8%), while Muleba (53.9%) and Muheza (61.6%) had low within-host diversity (Fws ≥ 0.95). PCA did not show any population structure and the mean FST value was 0.015. Low nucleotide diversity values were observed across the study sites (mean π = 0.00056). A total of 27 haplotypes were observed among the 313 monoclonal samples and under-fives exhibited higher haplotype counts. The Pf3D7 was detected as Hap_1, which occurred in 16/313 (5.1%) monoclonal sequences. Negative Tajima's D values were observed among the parasite populations in all the study sites. CONCLUSION Low levels of polymorphism in the pfrh5 gene were observed based on low nucleotide and haplotype diversity, a lack of population structure and negative Tajima's D values. This study provides essential data on the diversity of the Pfrh5 gene indicating that it can be considered in the development of the next generation malaria vaccines. Robust and intensive studies of this and other candidate genes are crucial to support the prioritization of the Pfrh5 gene for potential inclusion in a broadly cross-protective malaria vaccine.
Collapse
Affiliation(s)
| | - Dativa Pereus
- National Institute for Medical Research, Dar Es Salaam, Tanzania
- Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania
| | - Salehe S Mandai
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Beatus M Lyimo
- Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania
| | - Catherine Bakari
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Gervas A Chacha
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Ruth B Mbwambo
- National Institute for Medical Research, Dar Es Salaam, Tanzania
- Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania
| | - Ramadhan Moshi
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | | | - Daniel P Challe
- National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania
| | - Misago D Seth
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Rashid A Madebe
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Rule Budodo
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | | | | | | | - Stella Kajange
- President's Office, Regional Administration and Local Government, Dodoma, Tanzania
| | - Samwel Lazaro
- National Malaria Control Programme, Dodoma, Tanzania
| | - Ntuli Kapologwe
- Directorate of Preventive Services, Ministry of Health, Dodoma, Tanzania
| | - Celine I Mandara
- National Institute for Medical Research, Dar Es Salaam, Tanzania
| | - Deus S Ishengoma
- National Institute for Medical Research, Dar Es Salaam, Tanzania.
- Department of Biochemistry, Kampala International University in Tanzania, Dar Es Salaam, Tanzania.
| |
Collapse
|
24
|
Bald L, Ratnaweera N, Hengl T, Laube P, Grunder J, Tischhauser W, Bhandari N, Zeuss D. Assessing tick attachments to humans with citizen science data: spatio-temporal mapping in Switzerland from 2015 to 2021 using spatialMaxent. Parasit Vectors 2025; 18:22. [PMID: 39849565 PMCID: PMC11759452 DOI: 10.1186/s13071-024-06636-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Accepted: 12/16/2024] [Indexed: 01/25/2025] Open
Abstract
BACKGROUND Ticks are the primary vectors of numerous zoonotic pathogens, transmitting more pathogens than any other blood-feeding arthropod. In the northern hemisphere, tick-borne disease cases in humans, such as Lyme borreliosis and tick-borne encephalitis, have risen in recent years, and are a significant burden on public healthcare systems. The spread of these diseases is further reinforced by climate change, which leads to expanding tick habitats. Switzerland is among the countries in which tick-borne diseases are a major public health concern, with increasing incidence rates reported in recent years. METHODS In response to these challenges, the "Tick Prevention" app was developed by the Zurich University of Applied Sciences and operated by A&K Strategy Ltd. in Switzerland. The app allows for the collection of large amounts of data on tick attachment to humans through a citizen science approach. In this study, citizen science data were utilized to map tick attachment to humans in Switzerland at a 100 m spatial resolution, on a monthly basis, for the years 2015 to 2021. The maps were created using a state-of-the-art modeling approach with the software extension spatialMaxent, which accounts for spatial autocorrelation when creating Maxent models. RESULTS Our results consist of 84 maps displaying the risk of tick attachments to humans in Switzerland, with the model showing good overall performance, with median AUC ROC values ranging from 0.82 in 2018 to 0.92 in 2017 and 2021 and convincing spatial distribution, verified by tick experts for Switzerland. Our study reveals that tick attachment to humans is particularly high at the edges of settlement areas, especially in sparsely built-up suburban regions with green spaces, while it is lower in densely urbanized areas. Additionally, forested areas near cities also show increased risk levels. CONCLUSIONS This mapping aims to guide public health interventions to reduce human exposure to ticks and to inform the resource planning of healthcare facilities. Our findings suggest that citizen science data can be valuable for modeling and mapping tick attachment risk, indicating the potential of citizen science data for use in epidemiological surveillance and public healthcare planning.
Collapse
Affiliation(s)
- Lisa Bald
- Faculty of Geography, Environmental Informatics, University of Marburg, Deutschhausstraße 12, 35032, Marburg, Hessen, Germany.
| | - Nils Ratnaweera
- Institute of Natural Resource Sciences, Zurich University of Applied Sciences ZHAW, Grüentalstrasse 14, 8820, Wädenswil, Zürich, Switzerland
| | - Tomislav Hengl
- OpenGeoHub Foundation, Cardanuslaan 26, 6865HK, Doorwerth, The Netherlands
| | - Patrick Laube
- Institute of Natural Resource Sciences, Zurich University of Applied Sciences ZHAW, Grüentalstrasse 14, 8820, Wädenswil, Zürich, Switzerland
| | - Jürg Grunder
- A&K Strategy Ltd., Smartphone application "Tick Prevention", Chastelstrasse 14, 8732, Neuhaus, Zürich, Switzerland
| | - Werner Tischhauser
- A&K Strategy Ltd., Smartphone application "Tick Prevention", Chastelstrasse 14, 8732, Neuhaus, Zürich, Switzerland
| | - Netra Bhandari
- Faculty of Geography, Environmental Informatics, University of Marburg, Deutschhausstraße 12, 35032, Marburg, Hessen, Germany
| | - Dirk Zeuss
- Faculty of Geography, Environmental Informatics, University of Marburg, Deutschhausstraße 12, 35032, Marburg, Hessen, Germany
| |
Collapse
|
25
|
Logiudice J, Alberti M, Ciccarone A, Rossi B, Tiecco G, De Francesco MA, Quiros-Roldan E. Introduction of Vector-Borne Infections in Europe: Emerging and Re-Emerging Viral Pathogens with Potential Impact on One Health. Pathogens 2025; 14:63. [PMID: 39861024 PMCID: PMC11768692 DOI: 10.3390/pathogens14010063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2024] [Revised: 01/09/2025] [Accepted: 01/10/2025] [Indexed: 01/27/2025] Open
Abstract
The rise and resurgence of vector-borne diseases (VBDs) in Europe pose an expanding public health challenge, exacerbated by climate change, globalization, and ecological disruptions. Both arthropod-borne viruses (arboviruses) transmitted by ticks such as Crimean-Congo hemorrhagic fever and arboviruses transmitted by mosquitoes like dengue, Chikungunya, Zika, and Japanese encephalitis have broadened their distribution due to rising temperatures, changes in rainfall, and increased human mobility. By emphasizing the importance of interconnected human, animal, and environmental health, integrated One Health strategies are crucial in addressing this complex issue. Europe faces increased risk due to the expanding habitats of disease-carrying organisms, the spread of new species like Aedes albopictus since 2013, and increased movement of infected individuals between countries, leading European countries to implement strategies such as enhanced surveillance systems, public awareness campaigns, and prompt outbreak response strategies. However, the lack of both targeted antiviral therapies and vaccines for many arboviruses, together with undetected or asymptomatic cases, hamper containment efforts. Therefore, it is important to have integrated strategies that combine climate modeling, disease surveillance, and public health interventions to address expected changes in disease patterns due to global changes. This review explores the spread of arboviruses in Europe, highlighting their historical context, current transmission dynamics, and their impact on public health.
Collapse
Affiliation(s)
- Jacopo Logiudice
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy; (J.L.); (M.A.); (A.C.); (G.T.); (E.Q.-R.)
| | - Maria Alberti
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy; (J.L.); (M.A.); (A.C.); (G.T.); (E.Q.-R.)
| | - Andrea Ciccarone
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy; (J.L.); (M.A.); (A.C.); (G.T.); (E.Q.-R.)
| | - Benedetta Rossi
- Unit of Infectious and Tropical Diseases, ASST Spedali Civili di Brescia, 25123 Brescia, Italy;
- Department of Experimental Medicine and Public Health, School of Advanced Studies, University of Camerino, 62032 Camerino, Italy
| | - Giorgio Tiecco
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy; (J.L.); (M.A.); (A.C.); (G.T.); (E.Q.-R.)
| | - Maria Antonia De Francesco
- Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, 25123 Brescia, Italy
| | - Eugenia Quiros-Roldan
- Department of Clinical and Experimental Sciences, Unit of Infectious and Tropical Diseases, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy; (J.L.); (M.A.); (A.C.); (G.T.); (E.Q.-R.)
| |
Collapse
|
26
|
Miller FW. Environment, Lifestyles, and Climate Change: The Many Nongenetic Contributors to The Long and Winding Road to Autoimmune Diseases. Arthritis Care Res (Hoboken) 2025; 77:3-11. [PMID: 39228044 PMCID: PMC11684977 DOI: 10.1002/acr.25423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Revised: 09/15/2024] [Accepted: 08/15/2024] [Indexed: 09/05/2024]
Abstract
A critical unanswered question is what is causing the increase in the prevalence of autoimmunity and autoimmune diseases around the world. Given the rapidity of change, this is likely the result of major recent alterations in our exposures to environmental risk factors for these diseases. More evidence is becoming available that the evolution of autoimmune disease, years or even decades in the making, results from multiple exposures that alter susceptible genomes and immune systems over time. Exposures during sensitive phases in key developmental or hormonal periods may set the stage for the effects of later exposures. It is likely that synergistic and additive impacts of exposure mixtures result in chronic low-level inflammation. This inflammation may eventually pass thresholds that lead to immune system activation and autoimmunity, and with further molecular and pathologic changes, the complete clinical syndrome emerges. Much work remains to be done to define the mechanisms and risk and protective factors for autoimmune conditions. However, evidence points to a variety of pollutants, xenobiotics, infections, occupational exposures, medications, smoking, psychosocial stressors, changes in diet, obesity, exercise, and sleep patterns, as well as climate change impacts of increased heat, storms, floods, wildfires, droughts, UV radiation, malnutrition, and changing infections, as possible contributors. Substantial investments in defining the role of causal factors, in whom and when their effects are most important, the necessary and sufficient gene-environment interactions, improved diagnostics and therapies, and preventive strategies are needed now to limit the many negative personal, societal, and financial impacts that will otherwise occur.
Collapse
Affiliation(s)
- Frederick W. Miller
- National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle ParkNorth Carolina
| |
Collapse
|
27
|
Zavaleta-Monestel E, Rojas-Chinchilla C, Molina-Sojo P, Murillo-Castro MF, Rojas-Molina JP, Martínez-Vargas E. Impact of Climate Change on the Global Dynamics of Vector-Borne Infectious Diseases: A Narrative Review. Cureus 2025; 17:e77972. [PMID: 39996198 PMCID: PMC11849761 DOI: 10.7759/cureus.77972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/24/2025] [Indexed: 02/26/2025] Open
Abstract
Climate change has significantly altered the dynamics of vector-borne infectious diseases, favoring their proliferation and geographic expansion. Factors such as rising temperatures, the frequency of extreme weather events, and uncontrolled urbanization have increased the incidence of diseases such as dengue, Zika, chikungunya, malaria, and Lyme disease, especially in vulnerable regions with limited infrastructure. This article presents a narrative review based on recent scientific literature (2018-2025) to assess the impact of climate change on vector distribution, co-infections, and control strategies. The evidence collected highlights how changing climate conditions, combined with socioeconomic, political, and demographic factors, exacerbate public health crises and complicate mitigation efforts. It is concluded that facing this challenge requires a comprehensive strategy that combines environmental management, technological innovation, epidemiological surveillance, and community educational programs, promoting a coordinated global response to reduce the associated risks.
Collapse
|
28
|
Roth M, Geerling G, Strzalkowski P, Lindhof HH, Guthoff R. [Emerging pathogens of ocular infections due to environmental changes-What lies ahead?]. DIE OPHTHALMOLOGIE 2025; 122:31-36. [PMID: 39775877 DOI: 10.1007/s00347-024-02176-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/29/2024] [Revised: 09/29/2024] [Accepted: 12/18/2024] [Indexed: 01/11/2025]
Abstract
Due to the global effects of climate change numerous infectious diseases are increasingly spreading to regions that were previously hardly or only slightly affected. As ocular involvement is possible in many of these infectious diseases, we must also adapt to new pathogens and clinical pictures in Germany in the medium to long term. Using selected bacterial, viral and mycotic pathogens and diseases as examples, the causes of the increase in dissemination and the consequences for ophthalmology are presented.
Collapse
Affiliation(s)
- M Roth
- Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
| | - G Geerling
- Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland
| | - P Strzalkowski
- Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland
| | - H H Lindhof
- Klinik für Dermatologie, Universitätsklinikum Düsseldorf, Düsseldorf, Deutschland
| | - R Guthoff
- Klinik für Augenheilkunde, Universitätsaugenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland
| |
Collapse
|
29
|
Fukaura R, Ato M, Murase C, Miyamoto Y, Sugawara-Mikami M, Takahashi T, Hoshino Y, Fujimoto N, Akiyama M, Ishii N, Yotsu R. Buruli ulcer: An epidemiological update from Japan. J Dermatol 2025; 52:3-10. [PMID: 39350453 DOI: 10.1111/1346-8138.17483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2024] [Revised: 08/15/2024] [Accepted: 09/13/2024] [Indexed: 01/07/2025]
Abstract
Japan is one of the rare non-tropical countries with documented cases of Buruli ulcer (BU). Mycobacterium ulcerans subsp. shinshuense has been identified as the causative agent. The first report of BU in Japan dates back to 1982, with sporadic reports thereafter. Recently, the number of cases has been on the increase, and 50 cases (57.7%) are from the past decade alone, out of a total of 87 cases reported to date. Japan's well-developed healthcare facilities play a crucial role in enabling detailed investigations and providing appropriate treatment for patients, contributing to a favorable prognosis. However, the rarity of the disease results in lack of awareness among healthcare professionals, leading to frequent delays in diagnosis. This article aims to offer an updated overview of BU cases in Japan and to raise awareness of BU among dermatologists and other healthcare professionals in a non-endemic setting.
Collapse
Affiliation(s)
- Ryo Fukaura
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Manabu Ato
- Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | - Chiaki Murase
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | - Yuji Miyamoto
- Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | | | | | - Yoshihiko Hoshino
- Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan
| | - Noriki Fujimoto
- Department of Dermatology, Shiga University of Medical Science, Otsu, Japan
| | - Masashi Akiyama
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan
| | | | - Rie Yotsu
- Department of Tropical Medicine and Infectious Disease, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA
- Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan
- School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
| |
Collapse
|
30
|
Cody SG, Adam A, Siniavin A, Kang SS, Wang T. Flaviviruses-Induced Neurological Sequelae. Pathogens 2024; 14:22. [PMID: 39860983 PMCID: PMC11768111 DOI: 10.3390/pathogens14010022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 12/24/2024] [Accepted: 12/27/2024] [Indexed: 01/27/2025] Open
Abstract
Flaviviruses, a group of single-stranded RNA viruses spread by mosquitoes or ticks, include several significant neurotropic viruses, such as West Nile virus (WNV), Japanese encephalitis virus (JEV), tick-borne encephalitis virus (TBEV), and Zika virus (ZIKV). These viruses can cause a range of neurological diseases during acute infection, from mild, flu-like symptoms to severe and fatal encephalitis. A total of 20-50% of patients who recovered from acute flavivirus infections experienced long-term cognitive issues. Here, we discuss these major neurotropic flaviviruses-induced clinical diseases in humans and the recent findings in animal models and provide insights into the underlying disease mechanisms.
Collapse
Affiliation(s)
- Samantha Gabrielle Cody
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; (S.G.C.); (A.A.); (A.S.); (S.S.K.)
- Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA
| | - Awadalkareem Adam
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; (S.G.C.); (A.A.); (A.S.); (S.S.K.)
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA
| | - Andrei Siniavin
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; (S.G.C.); (A.A.); (A.S.); (S.S.K.)
| | - Sam S. Kang
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; (S.G.C.); (A.A.); (A.S.); (S.S.K.)
| | - Tian Wang
- Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA; (S.G.C.); (A.A.); (A.S.); (S.S.K.)
- Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA
- Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA
| |
Collapse
|
31
|
Ali A, Shaikh A, Sethi I, Surani S. Climate change and the emergence and exacerbation of infectious diseases: A review. World J Virol 2024; 13:96476. [PMID: 39722757 PMCID: PMC11551687 DOI: 10.5501/wjv.v13.i4.96476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Revised: 09/14/2024] [Accepted: 09/30/2024] [Indexed: 10/18/2024] Open
Abstract
Experts expressed severe concerns over the possibility of increasing burden of infectious diseases as the planet's climate began to change years ago. There have been increased rates of climate-related catastrophes and as global temperatures rise, emergence of certain viruses has become a serious concern. Vectors are susceptible to changing temperatures as they exhibit innate responses to thermal stress to increase survivability. Climate change impacts virus reservoirs, increasing transmission rates of vectors. Vector-borne diseases have already witnessed increasing numbers compared to before. Certain non-endemic areas are encountering their first-ever infectious disease cases due to increasing temperatures. Tick-borne diseases are undergoing transformations provoking a heightened prevalence. Food-borne illnesses are expected to increase owing to warmer temperatures. It is important to recognize that climate change has a multivariable impact on the transmission of viruses. With climate change comes the potential of increasing interspecies interactions promoting jumps. These factors must be considered, and an informed strategy must be formulated. Adaptation and mitigation strategies are required to curb these diseases from spreading. Despite significant evidence that climate change affects infectious diseases, gaps in research exist. We conducted this review to identify the potential role climate change plays in the emergence of new viruses.
Collapse
Affiliation(s)
- Amal Ali
- Department of Medicine, Aga Khan University, Karachi 74800, Sindh, Pakistan
| | - Asim Shaikh
- Department of Medicine, Dow Medical College, Karachi 74200, Sindh, Pakistan
| | - Imran Sethi
- Department of Critical Care Medicine, Marion General Hospital, Marion, IN 46952, United States
| | - Salim Surani
- Department of Medicine & Pharmacology, Texas A&M University, College Station, TX 77843, United States
- Department of Medicine, Aga Khan University, Nairobi 30270, Nairobi City, Kenya
| |
Collapse
|
32
|
Cagigi A, Tinnirello R, Iannolo G, Douradinha B. Orthoflavivirus zikaense (Zika) vaccines: What are we waiting for? Int J Antimicrob Agents 2024; 64:107367. [PMID: 39490448 DOI: 10.1016/j.ijantimicag.2024.107367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2024] [Revised: 10/08/2024] [Accepted: 10/20/2024] [Indexed: 11/05/2024]
Affiliation(s)
- Alberto Cagigi
- International Vaccine Institute (IVI) Europe Regional Office, Solna, Sweden
| | | | | | - Bruno Douradinha
- Vaccine Technology Subgroup, Emerging Pathogens Group, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
| |
Collapse
|
33
|
Lawrence TJ, Kangogo GK, Fredman A, Deem SL, Fèvre EM, Gluecks I, Brien JD, Shacham E. Spatial examination of social and environmental drivers of Middle East respiratory syndrome coronavirus (MERS-CoV) across Kenya. ECOHEALTH 2024; 21:155-173. [PMID: 38916836 PMCID: PMC11649862 DOI: 10.1007/s10393-024-01684-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/12/2023] [Revised: 03/28/2024] [Accepted: 04/10/2024] [Indexed: 06/26/2024]
Abstract
Climate and agricultural land-use change has increased the likelihood of infectious disease emergence and transmissions, but these drivers are often examined separately as combined effects are ignored. Further, seldom are the influence of climate and agricultural land use on emerging infectious diseases examined in a spatially explicit way at regional scales. Our objective in this study was to spatially examine the climate, agriculture, and socio-demographic factors related to agro-pastoralism, and especially the combined effects of these variables that can influence the prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels across northern Kenya. Our research questions focused on: (1) How MERS-CoV in dromedary camels has varied across geographic regions of northern Kenya, and (2) what climate, agriculture, and socio-demographic factors of agro-pastoralism were spatially related to the geographic variation of MERS-CoV cases in dromedary camels. To answer our questions, we analyzed the spatial distribution of historical cases based on serological evidence of MERS-CoV at the county level and applied spatial statistical analysis to examine the spatial relationships of the MERS-CoV cases between 2016 and 2018 to climate, agriculture, and socio-demographic factors of agro-pastoralism. Regional differences in MERS-CoV cases were spatially correlated with both social and environmental factors, and particularly ethno-religious camel practices, which highlight the complexity in the distribution of MERS-CoV in dromedary camels across Kenya.
Collapse
Affiliation(s)
| | - Geoffrey K Kangogo
- College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, USA
| | | | - Sharon L Deem
- Institute for Conservation Medicine, Saint Louis Zoo, St. Louis, MO, USA
| | - Eric M Fèvre
- University of Liverpool, Liverpool, England, UK
- International Livestock Research Institute, Nairobi, Kenya
| | - Ilona Gluecks
- International Livestock Research Institute, Nairobi, Kenya
| | | | - Enbal Shacham
- College for Public Health and Social Justice, Saint Louis University, St. Louis, MO, USA
| |
Collapse
|
34
|
Romanello M, Walawender M, Hsu SC, Moskeland A, Palmeiro-Silva Y, Scamman D, Ali Z, Ameli N, Angelova D, Ayeb-Karlsson S, Basart S, Beagley J, Beggs PJ, Blanco-Villafuerte L, Cai W, Callaghan M, Campbell-Lendrum D, Chambers JD, Chicmana-Zapata V, Chu L, Cross TJ, van Daalen KR, Dalin C, Dasandi N, Dasgupta S, Davies M, Dubrow R, Eckelman MJ, Ford JD, Freyberg C, Gasparyan O, Gordon-Strachan G, Grubb M, Gunther SH, Hamilton I, Hang Y, Hänninen R, Hartinger S, He K, Heidecke J, Hess JJ, Jamart L, Jankin S, Jatkar H, Jay O, Kelman I, Kennard H, Kiesewetter G, Kinney P, Kniveton D, Kouznetsov R, Lampard P, Lee JKW, Lemke B, Li B, Liu Y, Liu Z, Llabrés-Brustenga A, Lott M, Lowe R, Martinez-Urtaza J, Maslin M, McAllister L, McMichael C, Mi Z, Milner J, Minor K, Minx J, Mohajeri N, Momen NC, Moradi-Lakeh M, Morrisey K, Munzert S, Murray KA, Obradovich N, O'Hare MB, Oliveira C, Oreszczyn T, Otto M, Owfi F, Pearman OL, Pega F, Perishing AJ, Pinho-Gomes AC, Ponmattam J, Rabbaniha M, Rickman J, Robinson E, Rocklöv J, Rojas-Rueda D, Salas RN, Semenza JC, Sherman JD, Shumake-Guillemot J, Singh P, Sjödin H, Slater J, Sofiev M, Sorensen C, Springmann M, et alRomanello M, Walawender M, Hsu SC, Moskeland A, Palmeiro-Silva Y, Scamman D, Ali Z, Ameli N, Angelova D, Ayeb-Karlsson S, Basart S, Beagley J, Beggs PJ, Blanco-Villafuerte L, Cai W, Callaghan M, Campbell-Lendrum D, Chambers JD, Chicmana-Zapata V, Chu L, Cross TJ, van Daalen KR, Dalin C, Dasandi N, Dasgupta S, Davies M, Dubrow R, Eckelman MJ, Ford JD, Freyberg C, Gasparyan O, Gordon-Strachan G, Grubb M, Gunther SH, Hamilton I, Hang Y, Hänninen R, Hartinger S, He K, Heidecke J, Hess JJ, Jamart L, Jankin S, Jatkar H, Jay O, Kelman I, Kennard H, Kiesewetter G, Kinney P, Kniveton D, Kouznetsov R, Lampard P, Lee JKW, Lemke B, Li B, Liu Y, Liu Z, Llabrés-Brustenga A, Lott M, Lowe R, Martinez-Urtaza J, Maslin M, McAllister L, McMichael C, Mi Z, Milner J, Minor K, Minx J, Mohajeri N, Momen NC, Moradi-Lakeh M, Morrisey K, Munzert S, Murray KA, Obradovich N, O'Hare MB, Oliveira C, Oreszczyn T, Otto M, Owfi F, Pearman OL, Pega F, Perishing AJ, Pinho-Gomes AC, Ponmattam J, Rabbaniha M, Rickman J, Robinson E, Rocklöv J, Rojas-Rueda D, Salas RN, Semenza JC, Sherman JD, Shumake-Guillemot J, Singh P, Sjödin H, Slater J, Sofiev M, Sorensen C, Springmann M, Stalhandske Z, Stowell JD, Tabatabaei M, Taylor J, Tong D, Tonne C, Treskova M, Trinanes JA, Uppstu A, Wagner F, Warnecke L, Whitcombe H, Xian P, Zavaleta-Cortijo C, Zhang C, Zhang R, Zhang S, Zhang Y, Zhu Q, Gong P, Montgomery H, Costello A. The 2024 report of the Lancet Countdown on health and climate change: facing record-breaking threats from delayed action. Lancet 2024; 404:1847-1896. [PMID: 39488222 PMCID: PMC7616816 DOI: 10.1016/s0140-6736(24)01822-1] [Show More Authors] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2024] [Revised: 08/04/2024] [Accepted: 08/29/2024] [Indexed: 11/04/2024]
Abstract
Despite the initial hope inspired by the 2015 Paris Agreement, the world is now dangerously close to breaching its target of limiting global multiyear mean heating to 1·5°C. Annual mean surface temperature reached a record high of 1·45°C above the pre-industrial baseline in 2023, and new temperature highs were recorded throughout 2024. The resulting climatic extremes are increasingly claiming lives and livelihoods worldwide. The Lancet Countdown: tracking progress on health and climate change was established the same year the Paris Agreement entered into force, to monitor the health impacts and opportunities of the world’s response to this landmark agreement. Supported through strategic core funding from Wellcome, the collaboration brings together over 300 multidisciplinary researchers and health professionals from around the world to take stock annually of the evolving links between health and climate change at global, regional, and national levels. The 2024 report of the Lancet Countdown, building on the expertise of 122 leading researchers from UN agencies and academic institutions worldwide, reveals the most concerning findings yet in the collaboration’s 8 years of monitoring.
Collapse
Affiliation(s)
- Marina Romanello
- Institute for Global Health, University College London, London, UK.
| | - Maria Walawender
- Institute for Global Health, University College London, London, UK
| | - Shih-Che Hsu
- Energy Institute, University College London, London, UK
| | - Annalyse Moskeland
- Department of Geography and Environment, London School of Economics and Political Science, London, UK
| | | | - Daniel Scamman
- Institute for Sustainable Resources, University College London, London, UK
| | - Zakari Ali
- Medical Research Council Unit, The Gambia, London School of Hygiene & Tropical Medicine, Serekunda, The Gambia
| | - Nadia Ameli
- Institute for Sustainable Resources, University College London, London, UK
| | - Denitsa Angelova
- Institute for Sustainable Resources, University College London, London, UK
| | - Sonja Ayeb-Karlsson
- Department of Risk and Disaster Reduction, University College London, London, UK
| | - Sara Basart
- World Metereological Organization, Geneva, Switzerland
| | | | - Paul J Beggs
- School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, Australia
| | - Luciana Blanco-Villafuerte
- Centro Latino Americano de Excelencia en Cambio Climático y Salud, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Wenjia Cai
- Department of Earth System Science, Tsinghua University, Beijing, China
| | - Max Callaghan
- Mercator Research Institute on Global Commons and Climate Change, Berlin, Germany
| | | | | | - Victoria Chicmana-Zapata
- Intercultural Citizenship and Indigenous Health Unit, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Lingzhi Chu
- Yale Center on Climate Change and Health, Yale School of Public Health, Yale University, New Haven, CT, USA
| | - Troy J Cross
- Heat and Health Research Centre, University of Sydney, Sydney, NSW, Australia
| | | | - Carole Dalin
- Institute for Sustainable Resources, University College London, London, UK
| | - Niheer Dasandi
- School of Government, University of Birmingham, Birmingham, UK
| | - Shouro Dasgupta
- Euro-Mediterranean Center on Climate Change Foundation, Lecce, Italy
| | - Michael Davies
- Institute for Environmental Design and Engineering, University College London, London, UK
| | - Robert Dubrow
- Yale Center on Climate Change and Health, Yale School of Public Health, Yale University, New Haven, CT, USA
| | - Matthew J Eckelman
- Department of Civil and Environmental Engineering, Northeastern University, Boston, MA, USA
| | - James D Ford
- Priestley Centre for Climate Futures, University of Leeds, Leeds, UK
| | | | - Olga Gasparyan
- Department of Political Science, Florida State University, Tallahassee, FL, USA
| | - Georgiana Gordon-Strachan
- Tropical Metabolism Research Unit, Caribbean Institute for Health Research, University of the West Indies, Kingston, Jamaica
| | - Michael Grubb
- Institute for Sustainable Resources, University College London, London, UK
| | - Samuel H Gunther
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Ian Hamilton
- Energy Institute, University College London, London, UK
| | - Yun Hang
- Department of Environmental and Occupational Health Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA
| | | | - Stella Hartinger
- School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Kehan He
- Institute for Climate and Carbon Neutrality, University of Hong Kong, Hong Kong Special Administrative Region, China; University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Julian Heidecke
- Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany
| | - Jeremy J Hess
- Centre for Health and the Global Environment, University of Washington, Seattle, WA, USA
| | - Louis Jamart
- Institute for Global Health, University College London, London, UK
| | - Slava Jankin
- School of Government, University of Birmingham, Birmingham, UK
| | | | - Ollie Jay
- Heat and Health Research Centre, University of Sydney, Sydney, NSW, Australia
| | - Ilan Kelman
- Institute for Global Health, University College London, London, UK
| | - Harry Kennard
- Center on Global Energy Policy, Columbia University, New York, NY, USA
| | - Gregor Kiesewetter
- Pollution Management Group, Program on Energy, Climate and the Environment, International Institute for Applied Systems Analysis, Laxenburg, Austria
| | - Patrick Kinney
- Department of Environmental Health, School of Public Health, Boston University, Boston, MA, USA
| | | | | | - Pete Lampard
- Department of Health Sciences, University of York, York, UK
| | - Jason K W Lee
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Bruno Lemke
- Nelson Marlborough Institute of Technology-Te Pukenga, Nelson, New Zealand
| | - Bo Li
- School of Management, Beijing Institute of Technology, Beijing, China
| | - Yang Liu
- Emory University, Atlanta, GA, USA
| | - Zhao Liu
- Department of Earth System Science, Tsinghua University, Beijing, China
| | | | - Melissa Lott
- Center on Global Energy Policy, Columbia University, New York, NY, USA
| | - Rachel Lowe
- Catalan Institution for Research and Advanced Studies, Barcelona, Spain
| | - Jaime Martinez-Urtaza
- Department of Genetics and Microbiology, School of Biosciences, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Mark Maslin
- Department of Geography, University College London, London, UK
| | - Lucy McAllister
- Environmental Studies Program, Denison University, Granville, OH, USA
| | - Celia McMichael
- School of Geography, Earth and Atmospheric Sciences, University of Melbourne, Melbourne, VIC, Australia
| | - Zhifu Mi
- Bartlett School of Sustainable Construction, University College London, London, UK
| | - James Milner
- Department of Public Health, Environments, and Society, London School of Hygiene and Tropical Medicine, London, UK
| | - Kelton Minor
- Data Science Institute, Columbia University, New York, NY, USA
| | - Jan Minx
- Mercator Research Institute on Global Commons and Climate Change, Berlin, Germany
| | - Nahid Mohajeri
- Institute for Environmental Design and Engineering, University College London, London, UK
| | - Natalie C Momen
- Department of Environment, Climate Change and Health, WHO, Geneva, Switzerland
| | - Maziar Moradi-Lakeh
- Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Karyn Morrisey
- Department of Technology, Management and Economics, Technical University of Denmark, Copenhagen, Denmark
| | | | - Kris A Murray
- Medical Research Council Unit, The Gambia, London School of Hygiene & Tropical Medicine, Serekunda, The Gambia
| | - Nick Obradovich
- Laureate Institute for Brain Research, Massachusetts Institute of Technology, Tulsa, OK, USA
| | - Megan B O'Hare
- Institute for Global Health, University College London, London, UK
| | - Camile Oliveira
- Institute for Global Health, University College London, London, UK
| | | | - Matthias Otto
- Nelson Marlborough Institute of Technology-Te Pukenga, Nelson, New Zealand
| | - Fereidoon Owfi
- Agricultural Research, Education and Extension Organization, Iranian Fisheries Science Research Institute, Tehran, Iran
| | - Olivia L Pearman
- Social and Economic Analysis Branch, US Geological Survey, Fort Collins, OH, USA
| | - Frank Pega
- Department of Environment, Climate Change and Health, WHO, Geneva, Switzerland
| | | | | | - Jamie Ponmattam
- Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA
| | - Mahnaz Rabbaniha
- Agricultural Research, Education and Extension Organization, Iranian Fisheries Science Research Institute, Tehran, Iran
| | - Jamie Rickman
- Institute for Sustainable Resources, University College London, London, UK
| | | | - Joacim Rocklöv
- Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany
| | - David Rojas-Rueda
- Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA
| | - Renee N Salas
- Harvard Medical School, Harvard University, Boston, MA, USA
| | - Jan C Semenza
- Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden
| | - Jodi D Sherman
- Department of Anesthesiology, Yale School of Medicine, Yale University, New Haven, CT, USA
| | | | - Pratik Singh
- Interdisciplinary Centre for Scientific Computing, Heidelberg University, Heidelberg, Germany
| | - Henrik Sjödin
- Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden
| | - Jessica Slater
- Pollution Management Group, Program on Energy, Climate and the Environment, International Institute for Applied Systems Analysis, Laxenburg, Austria
| | | | - Cecilia Sorensen
- Mailman School of Public Health, Columbia University, New York, NY, USA
| | - Marco Springmann
- Nuffield Department of Population Health, University of Oxford, Oxford, UK
| | | | - Jennifer D Stowell
- Department of Environmental Health, School of Public Health, Boston University, Boston, MA, USA
| | - Meisam Tabatabaei
- Higher Institution Centre of Excellence, Institute of Tropical Aquaculture and Fisheries, Universiti Malaysia Terengganu, Terengganu, Malaysia
| | - Jonathon Taylor
- Department of Civil Engineering, Tampere University, Tampere, Finland
| | | | - Cathryn Tonne
- Barcelona Institute for Global Health, Barcelona, Spain
| | - Marina Treskova
- Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany
| | - Joaquin A Trinanes
- Department of Electronics and Computer Sciences, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
| | | | - Fabian Wagner
- Pollution Management Group, Program on Energy, Climate and the Environment, International Institute for Applied Systems Analysis, Laxenburg, Austria
| | - Laura Warnecke
- Pollution Management Group, Program on Energy, Climate and the Environment, International Institute for Applied Systems Analysis, Laxenburg, Austria
| | - Hannah Whitcombe
- Institute for Global Health, University College London, London, UK
| | - Peng Xian
- United States Navy Research Laboratory, Monterey, CA, USA
| | - Carol Zavaleta-Cortijo
- Intercultural Citizenship and Indigenous Health Unit, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - Chi Zhang
- School of Management, Beijing Institute of Technology, Beijing, China
| | - Ran Zhang
- Natural Language Learning Group, University of Mannheim, Mannheim, Germany
| | - Shihui Zhang
- Department of Earth System Science, Tsinghua University, Beijing, China
| | - Ying Zhang
- Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia
| | - Qiao Zhu
- Emory University, Atlanta, GA, USA
| | - Peng Gong
- Department of Geography, University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Hugh Montgomery
- Centre for Human Health and Performance, University College London, London, UK
| | - Anthony Costello
- Institute for Global Health, University College London, London, UK
| |
Collapse
|
35
|
Damtew YT, Tong M, Varghese BM, Anikeeva O, Hansen A, Dear K, Driscoll T, Zhang Y, Capon T, Bi P. The impact of temperature on non-typhoidal Salmonella and Campylobacter infections: an updated systematic review and meta-analysis of epidemiological evidence. EBioMedicine 2024; 109:105393. [PMID: 39418985 PMCID: PMC11530612 DOI: 10.1016/j.ebiom.2024.105393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2024] [Revised: 09/22/2024] [Accepted: 09/26/2024] [Indexed: 10/19/2024] Open
Abstract
BACKGROUND As temperatures rise, the transmission and incidence of enteric infections such as those caused by Salmonella and Campylobacter increase. This study aimed to review and synthesise the available evidence on the effects of exposure to ambient temperatures on non-typhoidal Salmonella and Campylobacter infections. METHODS A systematic search was conducted for peer-reviewed epidemiological studies published between January 1990 and March 2024, in PubMed, Scopus, Embase, and Web of Science databases. Original observational studies using ecological time-series, case-crossover or case-series study designs reporting the association between ambient temperature and non-typhoidal Salmonella and Campylobacter infections in the general population were included. A random-effects meta-analysis was performed to pool the relative risks (RRs) per 1 °C temperature increase, and further meta regression, and subgroup analyses by climate zone, temperature metrics, temporal resolution, lag period, and continent were conducted. The Navigation Guide systematic review methodology framework was used to assess the quality and strength of evidence. The study protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO). FINDINGS Out of 3472 results, 44 studies were included in this systematic review encompassing over one million cases each of Salmonella and Campylobacter infections. Geographically, the 44 studies covered 27 countries across five continents and most of the studies were from high income countries. The meta-analysis incorporated 23 Salmonella studies (65 effect estimates) and 15 Campylobacter studies (24 effect estimates). For each 1 °C rise in temperature, the risk of non-typhoidal Salmonella and Campylobacter infections increased by 5% (RR: 1.05, 95% CI: 1.04-1.06), and 5% (RR: 1.05, 95% CI: 1.04-1.07%), respectively, with varying risks across different climate zones. The overall evidence was evaluated as being of "high" quality, and the strength of the evidence was determined to be "sufficient" for both infections. INTERPRETATION These findings emphasise the relationship between temperature and the incidence of Salmonella and Campylobacter infections. It is crucial to exercise caution when generalising these findings, given the limited number of studies conducted in low and middle-income countries. Nevertheless, the results demonstrate the importance of implementing focused interventions and adaptive measures, such as the establishment of localised early warning systems and preventive strategies that account for climatic fluctuations. Furthermore, our research emphasises the ongoing need for surveillance and research efforts to monitor and understand the changing dynamics of temperature-related enteric infections in the context of climate change. FUNDING Australian Research Council Discovery Projects grant (ARC DP200102571) Program.
Collapse
Affiliation(s)
- Yohannes Tefera Damtew
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia; College of Health and Medical Sciences, Haramaya University, P.O.BOX 138, Dire Dawa, Ethiopia.
| | - Michael Tong
- National Centre for Epidemiology and Population Health, ANU College of Health and Medicine, The Australian National University, Canberra, ACT 2601, Australia.
| | - Blesson Mathew Varghese
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
| | - Olga Anikeeva
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
| | - Alana Hansen
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
| | - Keith Dear
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
| | - Tim Driscoll
- School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales 2006, Australia.
| | - Ying Zhang
- School of Public Health, Faculty of Medicine and Health, The University of Sydney, New South Wales 2006, Australia.
| | - Tony Capon
- Monash Sustainable Development Institute, Monash University, Melbourne, Victoria, Australia.
| | - Peng Bi
- School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
| |
Collapse
|
36
|
Bangoura ST, Sidibé S, Kaba L, Mbaye A, Hounmenou CG, Diallo A, Camara SC, Diaby M, Kadio KJJO, D’Ortenzio E, Camara A, Vanhems P, Delamou A, Delaporte E, Keita AK, Ottmann M, Touré A, Khanafer N. Seroprevalence of seven arboviruses of public health importance in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Glob Health 2024; 9:e016589. [PMID: 39486798 PMCID: PMC11529691 DOI: 10.1136/bmjgh-2024-016589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2024] [Accepted: 09/26/2024] [Indexed: 11/04/2024] Open
Abstract
BACKGROUND The arboviruses continue to be a threat to public health and socioeconomic development in sub-Saharan Africa (SSA). Seroprevalence surveys can be used as a population surveillance strategy for arboviruses in the absence of treatment and vaccines for most arboviruses, guiding the public health interventions. The objective of this study was to analyse the seroprevalence of arboviruses in SSA through a systematic review and meta-analysis. METHODS We searched PubMed/MEDLINE, Web of Science, Embase, Scopus and ScienceDirect databases for articles published between 2000 and 2022 reporting the seroprevalence of immunoglobulin G (IgG) antibodies to seven arboviruses in various human populations residing in SSA. The included studies were assessed using the checklist for assessing the risk of bias in prevalence studies, and the data were extracted using a standard form. A random effects model was used to estimate pooled seroprevalences. The potential sources of heterogeneity were explored through subgroup analyses and meta-regression. The protocol had been previously registered on International Prospective Register of Systematic Reviews with the identifier: CRD42022377946. RESULTS A total of 165 studies from 27 countries, comprising 186 332 participants, were included. Of these, 141 were low-risk and 24 were moderate-risk. The pooled IgG seroprevalence was 23.7% (17.9-30.0%) for Chikungunya virus, 22.7% (17.5-28.4%) for dengue virus, 22.6% (14.1-32.5%) for West Nile virus, 16.4% (7.1-28.5%) for yellow fever virus, 13.1% (6.4-21.7%) for Zika virus, 9.2% (6.5-12.3%) for Rift Valley fever virus and 6.0% (3.1-9.7) for Crimean-Congo haemorrhagic fever virus. Subgroup and meta-regression analyses showed that seroprevalence differed considerably between countries, study populations, specific age categories, sample sizes and laboratory methods. CONCLUSION This SRMA provides information on the significant circulation of various arboviruses in SSA, which is essential for the adoption and planning of vaccines. These findings suggest the need to invest in surveillance and research activities on arbovirus in SSA countries to increase our understanding of their epidemiology to prevent and respond to future epidemics.
Collapse
Affiliation(s)
- Salifou Talassone Bangoura
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Sidikiba Sidibé
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Lanceï Kaba
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
| | - Aminata Mbaye
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
| | | | - Alhassane Diallo
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | | | - Maladho Diaby
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Kadio Jean-Jacques Olivier Kadio
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Eric D’Ortenzio
- ANRS Maladies infectieuses émergentes (ANRS MIE), Inserm, Paris, France
- AP-HP, Hôpital Bichat, Service de maladies infectieuses et tropicales, Paris, France
| | - Alioune Camara
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Philippe Vanhems
- Infection Control Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
- PHE3ID team, Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, Lyon, France
| | - Alexandre Delamou
- African Centre of Excellence in the Prevention and Control of Communicable Diseases (CEA-PCMT), Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
- National Center for Training and Research in Rural Health of Maferinyah, Forécariah, Guinea
| | - Eric Delaporte
- TransVIHMI, Université de Montpellier-INSERM-IRD, Montpellier, France
| | - Alpha-Kabinet Keita
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
| | - Michèle Ottmann
- CIRI, Centre International de Recherche en Infectiologie (Team VirPath), Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France
| | - Abdoulaye Touré
- Centre de Recherche et de Formation en Infectiologie de Guinée, Conakry, Guinea
- Public Health Department, Faculty of Sciences and Health Techniques, Gamal Abdel Nasser University, Conakry, Guinea
| | - Nagham Khanafer
- Infection Control Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
- PHE3ID team, Centre International de Recherche en Infectiologie, Inserm U1111, CNRS UMR5308, ENS de Lyon, Lyon 1 University, Lyon, France
| |
Collapse
|
37
|
Ansah EW, Antiri EO, Awuah HK, Salu P, Adoripore J, Boakye AE. Impact of urban greening on population health in sub-Saharan Africa: a scoping review protocol. BMJ Open 2024; 14:e087638. [PMID: 39438109 PMCID: PMC11499854 DOI: 10.1136/bmjopen-2024-087638] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Accepted: 09/30/2024] [Indexed: 10/25/2024] Open
Abstract
INTRODUCTION The rate of urbanisation in sub-Saharan Africa (SSA) has increased remarkably, with the urban population expected to double by 2050. This rapid urbanisation, industrialisation and climate change pose serious public health challenges resulting from increased heat waves and other environmental changes. Urban greening holds promise as a climate change mitigation and adaptation strategy, leading to biodiversity conservation and enhancing the physical, mental and social well-being of the population. METHODS AND ANALYSIS This scoping review aims to identify and synthesise studies that investigated the availability and utilisation of green spaces, the factors that affect the utilisation of green spaces as well as the health impacts of urban greening in SSA. A systematic search will be conducted across multiple databases (MEDLINE, PubMed, JSTOR, SCOPUS and Green FILE) and grey literature sources for papers published up to 2024, in line with established scoping review frameworks. The data will be charted and extracted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, Extension for Scoping Reviews. We will further synthesise and use thematic analysis to fully understand the relationship between urban greening and population health in SSA. ETHICS AND DISSEMINATION Ethical approval will not be required because primary data will not be collected for the study. The results of this study come from published articles, which are publicly available. The results of the review will be submitted to a peer-reviewed journal for publication and presented at workshops and conferences. REGISTRATION The scoping review protocol has been registered on the Open Science Framework https://osf.io/nfh68.
Collapse
Affiliation(s)
- Edward Wilson Ansah
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
| | - Ebenezer Oduro Antiri
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
- Cardiometabolic Epidemiology Research Laboratory, University of Cape Coast, Cape Coast, Ghana
| | - Hilary Konadu Awuah
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
| | - Promise Salu
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
| | - John Adoripore
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
| | - Anthony Edward Boakye
- Department of Health, Physical Education, and Recreation, University of Cape Coast, Cape Coast, Ghana
| |
Collapse
|
38
|
Gizaw Z, Salubi E, Pietroniro A, Schuster-Wallace CJ. Impacts of climate change on water-related mosquito-borne diseases in temperate regions: A systematic review of literature and meta-analysis. Acta Trop 2024; 258:107324. [PMID: 39009235 DOI: 10.1016/j.actatropica.2024.107324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Revised: 07/04/2024] [Accepted: 07/12/2024] [Indexed: 07/17/2024]
Abstract
Mosquito-borne diseases are a known tropical phenomenon. This review was conducted to assess the mecha-nisms through which climate change impacts mosquito-borne diseases in temperate regions. Articles were searched from PubMed, Scopus, Web of Science, and Embase databases. Identification criteria were scope (climate change and mosquito-borne diseases), region (temperate), article type (peer-reviewed), publication language (English), and publication years (since 2015). The WWH (who, what, how) framework was applied to develop the research question and thematic analyses identified the mechanisms through which climate change affects mosquito-borne diseases. While temperature ranges for disease transmission vary per mosquito species, all are viable for temperate regions, particularly given projected temperature increases. Zika, chikungunya, and dengue transmission occurs between 18-34 °C (peak at 26-29 °C). West Nile virus establishment occurs at monthly average temperatures between 14-34.3 °C (peak at 23.7-25 °C). Malaria establishment occurs when the consecutive average daily temperatures are above 16 °C until the sum is above 210 °C. The identified mechanisms through which climate change affects the transmission of mosquito-borne diseases in temperate regions include: changes in the development of vectors and pathogens; changes in mosquito habitats; extended transmission seasons; changes in geographic spread; changes in abundance and behaviors of hosts; reduced abundance of mosquito predators; interruptions to control operations; and influence on other non-climate factors. Process and stochastic approaches as well as dynamic and spatial models exist to predict mosquito population dynamics, disease transmission, and climate favorability. Future projections based on the observed relations between climate factors and mosquito-borne diseases suggest that mosquito-borne disease expansion is likely to occur in temperate regions due to climate change. While West Nile virus is already established in some temperate regions, Zika, dengue, chikungunya, and malaria are also likely to become established over time. Moving forward, more research is required to model future risks by incorporating climate, environmental, sociodemographic, and mosquito-related factors under changing climates.
Collapse
Affiliation(s)
- Zemichael Gizaw
- Department of Geography and Planning, University of Saskatchewan, 117 Science Place, Saskatoon, Saskatchewan, S7N 5C8, Canada; Department of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Global Institute for Water Security, University of Saskatchewan, Saskatoon, Canada
| | - Eunice Salubi
- Department of Geography and Planning, University of Saskatchewan, 117 Science Place, Saskatoon, Saskatchewan, S7N 5C8, Canada
| | - Alain Pietroniro
- Schulich School of Engineering, University of Calgary, Calgary, 622 Collegiate Pl NW, Calgary, Alberta, T2N 4V8, Canada; Global Institute for Water Security, University of Saskatchewan, Saskatoon, Canada
| | - Corinne J Schuster-Wallace
- Department of Geography and Planning, University of Saskatchewan, 117 Science Place, Saskatoon, Saskatchewan, S7N 5C8, Canada; Global Institute for Water Security, University of Saskatchewan, Saskatoon, Canada.
| |
Collapse
|
39
|
Padilla-Pozo Á, Bartumeus F, Montalvo T, Sanpera-Calbet I, Valsecchi A, Palmer JRB. Assessing and correcting neighborhood socioeconomic spatial sampling biases in citizen science mosquito data collection. Sci Rep 2024; 14:22462. [PMID: 39341898 PMCID: PMC11439082 DOI: 10.1038/s41598-024-73416-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Accepted: 09/17/2024] [Indexed: 10/01/2024] Open
Abstract
Climatic, ecological, and socioeconomic factors are facilitating the spread of mosquito-borne diseases, heightening the importance of vector surveillance and control. Citizen science is proving to be an effective tool to track mosquito populations, but methods are needed to detect and account for small scale sampling biases in citizen science surveillance. In this article we combine two types of traditional mosquito surveillance records with data from the Mosquito Alert citizen science system to explore the ways in which the socioeconomic characteristics of urban neighborhoods result in sampling biases in citizen scientists' mosquito reports, while also shaping the spatial distribution of mosquito populations themselves. We use Barcelona, Spain, as an example, and focus on Aedes albopictus, an invasive vector species of concern worldwide. Our results suggest citizen scientists' sampling effort is focused more in Barcelona's lower and middle income census tracts than in its higher income ones, whereas Ae. albopictus populations are concentrated in the city's upper-middle income tracts. High resolution estimates of the spatial distribution of Ae. albopictus risk can be improved by controlling for citizen scientists' sampling effort, making it possible to provide better insights for efficiently targeting control efforts. Our methodology can be replicated in other cities faced with vector mosquitoes to improve public health responses to mosquito-borne diseases, which impose massive burdens on communities worldwide.
Collapse
Affiliation(s)
- Álvaro Padilla-Pozo
- Department of Sociology, Cornell University, Uris Hall, 109 Tower Rd, Ithaca, 14853, New York, United States of America.
- Cornell Population Center, Cornell University, Martha Van Rensselaer Hall, Ithaca, 14850, New York, United States of America.
- Centre d'Estudis Avançats de Blanes (CEAB-CSIC), Spanish National Research Council, Carrer Accés Cala Sant Francesc, 14, Blanes, 17300, Girona, Spain.
- Department of Political and Social Sciences, Universitat Pompeu Fabra, Ramon Trias Fargas, 25-27, Barcelona, 08005, Barcelona, Spain.
| | - Frederic Bartumeus
- Centre d'Estudis Avançats de Blanes (CEAB-CSIC), Spanish National Research Council, Carrer Accés Cala Sant Francesc, 14, Blanes, 17300, Girona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Passeig de Lluís Companys, 23, Barcelona, 08010, Barcelona, Spain
- Centre de Recerca Ecològica i Aplicacions Forestals (CREAF), Edifici C Facultad de ciencias y biociencias, Bellaterra, 08193, Barcelona, Spain
| | - Tomás Montalvo
- Agència de Salut Pública de Barcelona, Pl. de Lesseps, 1, Barcelona, 08023, Barcelona, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón 11, Planta 0, Madrid, 28029, Madrid, Spain
- Institut d'Investigació Biomédica Sant Pau, IIB St. Pau, Sant Quintí, 77-79, Barcelona, 08041, Barcelona, Spain
| | - Isis Sanpera-Calbet
- Department of Political and Social Sciences, Universitat Pompeu Fabra, Ramon Trias Fargas, 25-27, Barcelona, 08005, Barcelona, Spain
| | - Andrea Valsecchi
- Agència de Salut Pública de Barcelona, Pl. de Lesseps, 1, Barcelona, 08023, Barcelona, Spain
| | - John R B Palmer
- Department of Political and Social Sciences, Universitat Pompeu Fabra, Ramon Trias Fargas, 25-27, Barcelona, 08005, Barcelona, Spain.
| |
Collapse
|
40
|
Ni H, Cai X, Ren J, Dai T, Zhou J, Lin J, Wang L, Wang L, Pei S, Yao Y, Xu T, Xiao L, Liu Q, Liu X, Guo P. Epidemiological characteristics and transmission dynamics of dengue fever in China. Nat Commun 2024; 15:8060. [PMID: 39277600 PMCID: PMC11401889 DOI: 10.1038/s41467-024-52460-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2024] [Accepted: 09/06/2024] [Indexed: 09/17/2024] Open
Abstract
China has experienced successive waves of dengue epidemics over the past decade. Nationwide data on 95,339 dengue cases, 89 surveillance sites for mosquito density and population mobility between 337 cities during 2013-20 were extracted. Weekly dengue time series including time trends and harmonic terms were fitted using seasonal regression models, and the amplitude and peak timing of the annual and semiannual cycles were estimated. A data-driven model-inference approach was used to simulate the epidemic at city-scale and estimate time-evolving epidemiological parameters. We found that the geographical distribution of dengue cases was expanding, and the main imported areas as well as external sources of imported cases changed. Dengue cases were predominantly concentrated in southern China and it exhibited an annual peak of activity, typically peaking in September. The annual amplitude of dengue epidemic varied with latitude (F = 19.62, P = 0.0001), mainly characterizing by large in southern cities and small in northern cities. The effective reproduction number Reff across cities is commonly greater than 1 in several specific months from July to November, further confirming the seasonal fluctuations and spatial heterogeneity of dengue epidemics. The results of this national study help to better informing interventions for future dengue epidemics in China.
Collapse
Affiliation(s)
- Haobo Ni
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Xiaoyan Cai
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Jiarong Ren
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
| | - Tingting Dai
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Jiayi Zhou
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Jiumin Lin
- Department of Hepatology and Infectious Diseases, Second Affiliated Hospital of Shantou University Medical College, Shantou, China
| | - Li Wang
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China
| | - Lingxi Wang
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Sen Pei
- Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA
| | - Yunchong Yao
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Ting Xu
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Lina Xiao
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China
| | - Qiyong Liu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Department of Vector Control, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Xinjiang Key Laboratory of Vector-borne Infectious Diseases, Urumqi, Xinjiang, China.
| | - Xiaobo Liu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- Department of Vector Control, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Xinjiang Key Laboratory of Vector-borne Infectious Diseases, Urumqi, Xinjiang, China.
| | - Pi Guo
- Department of Preventive Medicine, Shantou University Medical College, Shantou, China.
| |
Collapse
|
41
|
Francian A, Flores-Garcia Y, Powell JR, Petrovsky N, Zavala F, Chackerian B. Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein, TRIO. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.09.05.611467. [PMID: 39282324 PMCID: PMC11398493 DOI: 10.1101/2024.09.05.611467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2024]
Abstract
Malaria is a highly lethal infectious disease caused by Plasmodium parasites. These parasites are transmitted to vertebrate hosts when mosquitoes of the Anopheles genus probe for a blood meal. Sporozoites, the infectious stage of Plasmodium , transit to the liver within hours of injection into the dermis. Vaccine efforts are hindered by the complexity of the parasite's lifecycle and the speed at which the infection is established in the liver. In an effort to enhance immunity against Plasmodium , we produced a virus-like particle (VLP)-based vaccine displaying an epitope of TRIO, an Anopheles salivary protein which has been shown to enhance mobility and dispersal of sporozoites in the dermis. Previous work demonstrated that passive immunization with TRIO offered protection from liver infection and acted synergistically with a Plasmodium targeted vaccine. Immunization of mice with TRIO VLPs resulted in high-titer and long-lasting antibody responses that did not significantly drop for over 18 months post-immunization. TRIO VLPs were similarly immunogenic when combined with an anti-malaria vaccine targeting the L9 epitope of the Plasmodium falciparum circumsporozoite protein.However, when used in a malaria challenge mouse model, TRIO VLPs only provided modest protection from infection and did not boost the protection provided by L9 VLPs.
Collapse
|
42
|
Li J, Docile HJ, Fisher D, Pronyuk K, Zhao L. Current Status of Malaria Control and Elimination in Africa: Epidemiology, Diagnosis, Treatment, Progress and Challenges. J Epidemiol Glob Health 2024; 14:561-579. [PMID: 38656731 PMCID: PMC11442732 DOI: 10.1007/s44197-024-00228-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2024] [Accepted: 04/10/2024] [Indexed: 04/26/2024] Open
Abstract
The African continent carries the greatest malaria burden in the world. Falciparum malaria especially has long been the leading cause of death in Africa. Climate, economic factors, geographical location, human intervention and unstable security are factors influencing malaria transmission. Due to repeated infections and early interventions, the proportion of clinically atypical malaria or asymptomatic plasmodium carriers has increased significantly, which easily lead to misdiagnosis and missed diagnosis. African countries have made certain progress in malaria control and elimination, including rapid diagnosis of malaria, promotion of mosquito nets and insecticides, intermittent prophylactic treatment in high-risk groups, artemisinin based combination therapies, and the development of vaccines. Between 2000 and 2022, there has been a 40% decrease in malaria incidence and a 60% reduction in mortality rate in the WHO African Region. However, many challenges are emerging in the fight against malaria in Africa, such as climate change, poverty, substandard health services and coverage, increased outdoor transmission and the emergence of new vectors, and the growing threat of resistance to antimalarial drugs and insecticides. Joint prevention and treatment, identifying molecular determinants of resistance, new drug development, expanding seasonal malaria chemo-prevention intervention population, and promoting the vaccination of RTS, S/AS01 and R21/Matrix-M may help to solve the dilemma. China's experience in eliminating malaria is conducive to Africa's malaria prevention and control, and China-Africa cooperation needs to be constantly deepened and advanced. Our review aims to help the global public develop a comprehensive understanding of malaria in Africa, thereby contributing to malaria control and elimination.
Collapse
Affiliation(s)
- Jiahuan Li
- Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China
| | - Haragakiza Jean Docile
- Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China
| | - David Fisher
- Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa
| | - Khrystyna Pronyuk
- Department of Infectious Diseases, O. Bogomolets National Medical University, Kyiv, Ukraine
| | - Lei Zhao
- Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
| |
Collapse
|
43
|
Cunningham N, Jenkins C, Williams S, Garner J, Eggen B, Douglas A, Potter T, Wilson A, Leonardi G, Larkin L, Hopkins S. An outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with contaminated lettuce and the cascading risks from climate change, the United Kingdom, August to September 2022. Euro Surveill 2024; 29. [PMID: 39239728 PMCID: PMC11378517 DOI: 10.2807/1560-7917.es.2024.29.36.2400161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/07/2024] Open
Abstract
Shiga-toxin producing Escherichia coli (STEC) O157 is a food-borne pathogen which causes gastrointestinal illness in humans. Ruminants are considered the main reservoir of infection, and STEC exceedance has been associated with heavy rainfall. In September 2022, a large outbreak of STEC O157:H7 was identified in the United Kingdom (UK). A national-level investigation was undertaken to identify the source of the outbreak and inform risk mitigation strategies. Whole genome sequencing (WGS) was used to identify outbreak cases. Overall, 259 cases with illness onset dates between 5 August and 12 October 2022, were confirmed across the UK. Epidemiological investigations supported a UK grown, nationally distributed, short shelf-life food item as the source of the outbreak. Analytical epidemiology and food chain analysis suggested lettuce as the likely vehicle of infection. Food supply chain tracing identified Grower X as the likely implicated producer. Independent of the food chain investigations, a novel geospatial analysis triangulating meteorological, flood risk, animal density and land use data was developed, also identifying Grower X as the likely source. Novel geospatial analysis and One Health approaches are potential tools for upstream data analysis to predict and prevent contamination events before they occur and to support evidence generation in outbreak investigations.
Collapse
Affiliation(s)
- Neil Cunningham
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Claire Jenkins
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Sarah Williams
- United Kingdom Field Epidemiology Training Programme, United Kingdom Health Security Agency (UKHSA), London, United Kingdom
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Joanna Garner
- United Kingdom Field Epidemiology Training Programme, United Kingdom Health Security Agency (UKHSA), London, United Kingdom
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Bernd Eggen
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Amy Douglas
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Tina Potter
- Food Standards Agency (FSA), London, United Kingdom
| | | | - Giovanni Leonardi
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Lesley Larkin
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| | - Susan Hopkins
- United Kingdom Health Security Agency (UKHSA), London, United Kingdom
| |
Collapse
|
44
|
Sharif F, Shahzad L, Batool M. The association between climatic factors and waterborne infectious outbreaks with a focus on vulnerability in Pakistan: integrative review. INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH 2024; 34:3299-3316. [PMID: 38195067 DOI: 10.1080/09603123.2024.2302040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Accepted: 12/31/2023] [Indexed: 01/11/2024]
Abstract
Climate change affects the spread of waterborne infectious diseases, yet research on vulnerability to outbreaks remains limited. This integrative review examines how climate variables (temperature and precipitation) relate to human vulnerability factors in Pakistan. By 2060, mean temperatures are projected to rise from 21.68°C (2021) to 30°C, with relatively stable precipitation. The epidemiological investigation in Pakistan identified Diarrhea (119,000 cases/year), Malaria (2.6 million cases/year), and Hepatitis (A and E) as the most prevalent infections. This research highlighted vulnerability factors, including poverty (52% of the population), illiteracy (59% of the population), limited healthcare accessibility (55% of the population), malnutrition (38% of the population), dietary challenges (48% of the population), as well as exposure to water pollution (80% of the population) and air pollution (55% of the population). The findings suggest that the coordinated strategies are vital across health, environmental, meteorological, and social sectors, considering climatic variability patterns and population vulnerability determinants.
Collapse
Affiliation(s)
- Faiza Sharif
- Sustainable development study center (SDSC), Government College University, Lahore, Pakistan
| | - Laila Shahzad
- Sustainable development study center (SDSC), Government College University, Lahore, Pakistan
| | - Masooma Batool
- Sustainable development study center (SDSC), Government College University, Lahore, Pakistan
| |
Collapse
|
45
|
Niebank M, Brockmann SO, Feldt T, Jensen BEO, Jurke A, Mikolajewska A, Rothfuss K, Schauer J, Schmiedel S, Stegemann M, Tinnemann P, Uhrig A, Wolf T. The Role of High-Level Isolation Units in Response to High-Consequence and Emerging Infectious Diseases: Experience of the German STAKOB Network. Health Secur 2024; 22:S97-S103. [PMID: 39178134 DOI: 10.1089/hs.2023.0156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/25/2024] Open
Abstract
This case study describes the experience of the German Permanent Working Group of Competence and Treatment Centers for High Consequence Infectious Diseases, known as STAKOB (Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger). STAKOB brings together public health authorities (competence centers) and high-level isolation units (treatment centers) to collaborate on the clinical management of high-consequence infectious diseases (HCIDs) and emerging infectious diseases. The network is coordinated by the Robert Koch Institute, Germany's federal public health institute. The main tasks of STAKOB are to strengthen HCID clinical and public health management and increase expert knowledge on HCID and non-HCID emerging infectious diseases in Germany. STAKOB enables the exchange of knowledge and experiences; development of guidelines on infection prevention and control measures, clinical management, and therapy; and support for the World Health Organization and other outbreak responses internationally. The past years have shown how important the STAKOB network is for Germany-not only in providing critical care for HCID cases but also increasing capacity to support public health and clinical management of emerging infectious disease cases. However, maintaining several high-level isolation units in Germany requires a high commitment of financial, material, and human resources. Due to the rarity of HCID and emerging infectious disease events, maintaining the appropriate level of preparedness and ensuring sufficient investments is an ongoing struggle. Nevertheless, it is essential to have a network ready to react to HCID and non-HCID emerging infectious diseases in times of a changing biosecurity and infectious landscape.
Collapse
Affiliation(s)
- Michaela Niebank
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Stefan O Brockmann
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Torsten Feldt
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Björn-Erik Ole Jensen
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Annette Jurke
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Agata Mikolajewska
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Katja Rothfuss
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Jennifer Schauer
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Stefan Schmiedel
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Miriam Stegemann
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Peter Tinnemann
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Alexander Uhrig
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| | - Timo Wolf
- Michaela Niebank, MD, is Head, Clinical Management and Infection Control, and Head, STAKOB office; and Agata Mikolajewska, MD, is a Staff Member and Coordinator, STAKOB office; both at the Center for Biological Threats and Special Pathogens, Robert Koch Institute, Berlin, Germany. Stefan O. Brockmann, MD, is Head, Landesgesundheitsamt Referat 73, Ministerium für Soziales, Gesundheit und Integration Baden-Württemberg, Stuttgart, Germany. Torsten Feldt, MD, DTM, is an Infectious Disease Physician, Professor, and Head, Tropical Medicine Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Björn-Erik Ole Jensen, MD, PD, DTM, is Coordinator, High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Infectious Diseases, Düsseldorf University Hospital, and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. Annette Jurke, PD, MSc, is Speaker, STAKOB, and Head; and Jennifer Schauer, PhD, is a Staff Member; both in the Infectious Disease Epidemiology Section, NRW Centre for Health, Bochum, Germany. Katja Rothfuss, MD, is Coordinator High-Level Isolation Unit, Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. Stefan Schmiedel, MD, PhD, DTMPH, is a Consultant, Infectious Disease and Tropical Medicine, and Coordinator, High Level Isolation Unit, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany. Miriam Stegemann, MD, DTMH, is Head, Infectiology, Campus Virchow-Klinikum, Head of Antibiotic Stewardship, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Peter Tinnemann, MD, PD, MPH, is Head, Gesundheitsamt Frankfurt, Frankfurt am Main, Germany. Alexander Uhrig, MD, is Medical Director, Medical Intensive Care Unit/High-level Isolation Unit, Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Timo Wolf, MD, PD, DTM, is Speaker, STAKOB, and Head, High-level Isolation Unit, Internal Medicine, Infectious Diseases, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
| |
Collapse
|
46
|
Rodriguez J. One Health Ethics and the Ethics of Zoonoses: A Silent Call for Global Action. Vet Sci 2024; 11:394. [PMID: 39330773 PMCID: PMC11435914 DOI: 10.3390/vetsci11090394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Revised: 08/10/2024] [Accepted: 08/12/2024] [Indexed: 09/28/2024] Open
Abstract
This paper presents a critical review of key issues related to the emergence of new networks for the spread of zoonotic diseases amid the mass extinction of species. Zoonotic and infectious diseases account for approximately 70% of new and existing diseases affecting humans and animals. The initial section argues that the term "zoonoses" should not be confined to single-cause events within veterinary medicine. Instead, zoonoses should be viewed as complex, systemic phenomena shaped by interrelated factors, including environmental, sociocultural, and economic elements, influenced by anthropogenic climate change. The second section presents bioethical principles and potential strategies for those engaged in zoonotic disease prevention. The third section uses the slaughter of animals in disaster settings as a case study to illustrate the need for further clarification of normative and interspecies justice conflicts in One Health ethics. This section concludes with an outlook on "zoonoethics". Section four develops the analysis of the interlinked elements that trigger zoonoses and examines antimicrobial resistance (AMR) from an ethical and political standpoint, concluding with policy recommendations for addressing AMR. Section five offers a critical reflection, integrating contributions from zoonoethics, human ecology, and the ecotheological turn. Finally, section six concludes with a call to action and policy recommendations for an inclusive, intercultural, and gender-sensitive One Health approach.
Collapse
Affiliation(s)
- Jeyver Rodriguez
- Department of Applied Ethics, Temuco Catholic University, Temuco 4780000, Chile
- Cape Horn International Center for Global Change Studies and Biocultural Conservation (CHIC), Cabo de Hornos 635000, Chile
| |
Collapse
|
47
|
Knoblauch S, Su Yin M, Chatrinan K, de Aragão Rocha AA, Haddawy P, Biljecki F, Lautenbach S, Resch B, Arifi D, Jänisch T, Morales I, Zipf A. High-resolution mapping of urban Aedes aegypti immature abundance through breeding site detection based on satellite and street view imagery. Sci Rep 2024; 14:18227. [PMID: 39107395 PMCID: PMC11303731 DOI: 10.1038/s41598-024-67914-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Accepted: 07/17/2024] [Indexed: 08/10/2024] Open
Abstract
Identification of Aedes aegypti breeding hotspots is essential for the implementation of targeted vector control strategies and thus the prevention of several mosquito-borne diseases worldwide. Training computer vision models on satellite and street view imagery in the municipality of Rio de Janeiro, we analyzed the correlation between the density of common breeding grounds and Aedes aegypti infestation measured by ovitraps on a monthly basis between 2019 and 2022. Our findings emphasized the significance (p ≤ 0.05) of micro-habitat proxies generated through object detection, allowing to explain high spatial variance in urban abundance of Aedes aegypti immatures. Water tanks, non-mounted car tires, plastic bags, potted plants, and storm drains positively correlated with Aedes aegypti egg and larva counts considering a 1000 m mosquito flight range buffer around 2700 ovitrap locations, while dumpsters, small trash bins, and large trash bins exhibited a negative association. This complementary application of satellite and street view imagery opens the pathway for high-resolution interpolation of entomological surveillance data and has the potential to optimize vector control strategies. Consequently it supports the mitigation of emerging infectious diseases transmitted by Aedes aegypti, such as dengue, chikungunya, and Zika, which cause thousands of deaths each year.
Collapse
Affiliation(s)
- Steffen Knoblauch
- GIScience Chair, Heidelberg University, 69120, Heidelberg, Germany.
- Interdisciplinary Center of Scientific Computing, Heidelberg University, 69120, Heidelberg, Germany.
- Heidelberg Institute for Geoinformation Technology, 69118, Heidelberg, Germany.
| | - Myat Su Yin
- Faculty of ICT, Mahidol University, 73170, Nakhon Pathom, Thailand
| | | | | | - Peter Haddawy
- Faculty of ICT, Mahidol University, 73170, Nakhon Pathom, Thailand
- Bremen Spatial Cognition Center, University of Bremen, 28359, Bremen, Germany
| | - Filip Biljecki
- Department of Architecture, National University of Singapore, 117566, Singapore, Singapore
- Department of Real Estate, National University of Singapore, 119245, Singapore, Singapore
| | - Sven Lautenbach
- Heidelberg Institute for Geoinformation Technology, 69118, Heidelberg, Germany
| | - Bernd Resch
- Geo-social Analytics Lab, Paris Lodron University of Salzburg, 5020, Salzburg, Austria
- Center for Geographic Analysis, Harvard University, 02138, Cambridge, USA
| | - Dorian Arifi
- Geo-social Analytics Lab, Paris Lodron University of Salzburg, 5020, Salzburg, Austria
| | - Thomas Jänisch
- Colorado School of Public Health, University of Colorado Anschutz Medical Campus, 80045, Aurora, USA
- Heidelberg Institute of Global Health, Heidelberg University Hospital, 69120, Heidelberg, Germany
| | - Ivonne Morales
- Colorado School of Public Health, University of Colorado Anschutz Medical Campus, 80045, Aurora, USA
| | - Alexander Zipf
- GIScience Chair, Heidelberg University, 69120, Heidelberg, Germany
- Interdisciplinary Center of Scientific Computing, Heidelberg University, 69120, Heidelberg, Germany
- Heidelberg Institute for Geoinformation Technology, 69118, Heidelberg, Germany
| |
Collapse
|
48
|
Day ME, Puello YC, Mejía Sang ME, Diaz Brockmans EJ, Díaz Soto MF, Rivera Defilló SM, Taveras Cruz KM, Santiago Pérez JO, Meña R, Mota C, Hostetter MK, Muglia LJ, del Rey JG, Schlaudecker EP, Martin LJ, Simpson BN, Prada CE. Complete Blood Count Values Over Time in Young Children During the Dengue Virus Epidemic in the Dominican Republic From 2018 to 2020. BIOMED RESEARCH INTERNATIONAL 2024; 2024:3716786. [PMID: 39130533 PMCID: PMC11316910 DOI: 10.1155/2024/3716786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/01/2024] [Revised: 07/09/2024] [Accepted: 07/13/2024] [Indexed: 08/13/2024]
Abstract
Background: Dengue fever (DF) is a mosquito-borne illness with substantial economic and societal impact. Understanding laboratory trends of hospitalized Dominican Republic (DR) pediatric patients could help develop screening procedures in low-resourced settings. We sought to describe laboratory findings over time in DR children with DF and DF severity from 2018 to 2020. Methods: Clinical information was obtained prospectively from recruited children with DF. Complete blood count (CBC) laboratory measures were assessed across Days 1-10 of fever. Participants were classified as DF-negative and DF-positive and grouped by severity. We assessed associations of DF severity with demographics, clinical characteristics, and peripheral blood studies. Using linear mixed-models, we assessed if hematologic values/trajectories differed by DF status/severity. Results: A total of 597 of 1101 with a DF clinical diagnosis were serologically evaluated, and 574 (471 DF-positive) met inclusion criteria. In DF, platelet count and hemoglobin were higher on earlier days of fever (p < = 0.0017). Eighty had severe DF. Severe DF risk was associated with thrombocytopenia, intraillness anemia, and leukocytosis, differing by fever day (p < = 0.001). Conclusions: In a pediatric hospitalized DR cohort, we found marked anemia in late stages of severe DF, unlike the typically seen hemoconcentration. These findings, paired with clinical symptom changes over time, may help guide risk-stratified screenings for resource-limited settings.
Collapse
Affiliation(s)
- Melissa E. Day
- Division of Infectious DiseasesCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Yonairy Collado Puello
- School of MedicineInstituto Tecnológico de Santo Domingo, Santo Domingo, Dominican Republic
| | - Miguel E. Mejía Sang
- School of MedicineInstituto Tecnológico de Santo Domingo, Santo Domingo, Dominican Republic
| | | | - María F. Díaz Soto
- School of MedicineInstituto Tecnológico de Santo Domingo, Santo Domingo, Dominican Republic
| | | | - Karla M. Taveras Cruz
- School of MedicineInstituto Tecnológico de Santo Domingo, Santo Domingo, Dominican Republic
| | | | - Rafael Meña
- Department of PediatricsCentro de Obstetricia y Ginecología, Santo Domingo, Dominican Republic
| | - Cesár Mota
- Pediatric Emergency Medicine DepartmentHospital Infantil Dr. Robert Reid, Santo Domingo, Dominican Republic
| | - Margaret K. Hostetter
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - Louis J. Muglia
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Human GeneticsCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Javier Gonzalez del Rey
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Pediatric Emergency MedicineCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Elizabeth P. Schlaudecker
- Division of Infectious DiseasesCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - Lisa J. Martin
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Human GeneticsCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| | - Brittany N. Simpson
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Human GeneticsCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
- St. Jude Children's Research HospitalDepartment of PediatricsUniversity of Tennessee Health Science CenterLe Bonheur Children's Hospital, Memphis, Tennesse, USA
| | - Carlos E. Prada
- Department of PediatricsUniversity of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Division of Human GeneticsCincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
- Division of GeneticsBirth Defects & MetabolismAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
- Department of PediatricsFeinberg School of Medicine of Northwestern University, Chicago, Illinois, USA
| |
Collapse
|
49
|
Doering-White J, Díaz de León A, Hernández Tapia A, Delgado Mejía L, Castro S, Roy K, Cruz GQ, Hudock-Jeffrey S. Climate-health risk (In)visibility in the context of everyday humanitarian practice. Soc Sci Med 2024; 354:117081. [PMID: 38971042 DOI: 10.1016/j.socscimed.2024.117081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 05/16/2024] [Accepted: 06/27/2024] [Indexed: 07/08/2024]
Abstract
Nongovernmental migrant shelters in Mexico play a key role in documenting the factors that shape forced migration from Central America. Existing intake protocols in shelters are largely oriented to humanitarian legal frameworks that determine eligibility for international protection based on interpersonal violence and political persecution. This qualitative study calls attention to how existing humanitarian logics may obscure climate- and health-related disruptions as drivers of forced migration from Central America in the context of everyday humanitarian practice. In May 2022 we compared migrant's responses (n = 40) to a standardized intake protocol at a nongovernmental humanitarian migrant shelter in Mexico with responses to semi-structured interviews that focused on migrants' perceptions of climate change and health as drivers of forced displacement. We found that slow- and rapid-onset climatic disruptions; illness and disease; and various forms of violence and repression are often interrelated drivers of forced displacement. Comparing intake protocols and in-depth interview responses, we found that climate- and health-related drivers of forced displacement are rarely documented. These findings speak to the importance of critically examining everyday humanitarian practices in the context of ongoing advocacy that calls for climate-related disruptions to be integrated into existing humanitarian protection frameworks.
Collapse
|
50
|
Obeagu EI, Obeagu GU. Adapting to the shifting landscape: Implications of climate change for malaria control: A review. Medicine (Baltimore) 2024; 103:e39010. [PMID: 39029063 PMCID: PMC11398779 DOI: 10.1097/md.0000000000039010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Accepted: 06/28/2024] [Indexed: 07/21/2024] Open
Abstract
Malaria, a global public health challenge, continues to affect millions of lives, particularly in regions where its transmission is endemic. The interplay between climate change and malaria dynamics has emerged as a critical concern, reshaping the landscape of this vector-borne disease. This review publication, titled "Adapting to the shifting landscape: Implications of climate change for malaria control," explores the multifaceted relationship between climate change and the control of malaria. The paper begins by dissecting the influence of climate change on malaria dynamics, including alterations in temperature, precipitation, and other climatic factors that impact the habitat and life cycle of malaria vectors. It delves into the evolving ecology and behavior of malaria vectors in response to changing climatic conditions, emphasizing the importance of understanding these adaptations. As a response to this shifting landscape, the review discusses adaptive strategies for malaria control, ranging from vector control measures to the utilization of climate data in early warning systems. Community engagement and education are highlighted as essential components of these strategies, recognizing the vital role of local communities in effective malaria control efforts. The paper also identifies future directions and research needs, underscoring the importance of staying ahead of the evolving climate-malaria relationship. This review underscores the urgency of adapting to the changing landscape of malaria transmission driven by climate change. It emphasizes the significance of proactively addressing climate-related challenges to enhance malaria control and protect the health and well-being of vulnerable populations.
Collapse
|